| Package | hl7.fhir.uv.livd |
| Type | CodeSystem |
| Id | loinc-fragment-livd |
| FHIR Version | R4 |
| Source | http://hl7.org/fhir/uv/livd/https://build.fhir.org/ig/HL7/livd/CodeSystem-loinc-fragment-livd.html |
| URL | http://loinc.org |
| Version | 2.65 |
| Status | active |
| Date | 2024-12-19T18:01:42+00:00 |
| Name | LOINC |
| Title | LOINC Code System |
| Realm | uv |
| Authority | hl7 |
| Copyright | This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use |
| Content | fragment |
| CodeSystem | |
| supplement | LOINC Code System Supplement |
| loinc-supplement-translations | SupplementalLoincTranslations |
| ConceptMap | |
| EMISSectionHeaders | EMIS Consultation Section Headers Mapping |
| PlaceOfInjuryCM | PlaceOfInjury Concept Map |
| ch-elm-expecting-organism-specification-to-results-completion-vs | CH ELM Expecting Organism Specification To Results Completion Vs |
| ch-elm-expecting-specimen-specification-to-results-completion-vs | CH ELM Expecting Specimen Specification To Results Completion Vs |
| ch-elm-results-geno-to-component-code | CH ELM Results Genotype To Component Code |
| ch-elm-results-geno-to-component-interpretation-code | CH ELM Results Genotyping To Component Interpretation Code |
| ch-elm-results-susc-to-component-code | CH ELM Results Susceptibility To Component Code |
| ch-elm-results-susc-to-component-interpretation-code | CH ELM Results Susceptibility To Component Interpretation Code |
| ch-elm-results-susc-to-component-observation-profile | CH ELM Results Susceptibility To Component Observation Profile |
| ch-elm-results-to-foph-patient-name-representation | CH ELM Results To FOPH Patient Name Representation |
| ch-elm-results-to-interpretation-code | CH ELM Results To Interpretation Code |
| ch-elm-results-to-observation-profile | CH ELM Results To Observation Profile |
| nhi-loinc | 臺灣健保署醫療服務給付項目對應LOINC |
| activitydefinition-code-to-do-missing-measurement | Activitydefinition-code to do missing measurement |
| activitydefinition-code-to-do-reminder | Activitydefinition-code to do reminder |
| activitydefinition-code-to-measurement-resource-type | Activitydefinition-code to measurement resource type |
| activitydefinition-code-to-observation-code | ActivityDefinition code to Observation code |
| activitydefinition-code-to-perform-sharing | Activitydefinition-code-to-perform-sharing |
| conceptmap-obs-code-to-ucum | Observation code to UCUM mapping |
| conceptmap-obs-code-to-value-type | conceptmap-obs-code-to-value-type |
| CF-ProblemCategory | C-CDA section to FHIR Condition category code |
| FC-ProblemCategory | FHIR Condition category to C-CDA section code |
| lab-test-type-covid19-loinc-to-icd11 | Lab Test – Type - Mapping LOINC to ICD-11 |
| lab-test-type-snomed-to-icd11 | Lab Test - Pathogen - Mapping SNOMED CT to ICD-11 |
| who-ddcc-map-ichi-loinc-type-of-test | ConceptMap from ICHI to LOINC for Type of Test |
| who-ddcc-map-loinc-sct-type-of-test | ConceptMap from LOINC to SNOMED CT for Type of Test |
| CGMSummaryToLoinc | Mapping from CGM Temporary Codes to LOINC |
| CIELtoLOINCObservationMap | CIEL to LOINC Observation Code Map |
| CIELtoLoincDiagnosticReportMap | CIEL → LOINC DiagnosticReport .code Map (breast-imaging + chest US) |
| direct-alerts | Direct ADT to Da Vinci Alerts ConceptMap |
| LOINC | LOINC |
| IMMZ.C.ConceptMap | ConceptMap to and from IMMZ.C DataElements |
| IMMZ.D.ConceptMap | ConceptMap to and from IMMZ.D DataElements |
| IMMZ.Z.ConceptMap | ConceptMap to and from IMMZ.Z DataElements |
| dna-change-type-map | DNA Change Type Map |
| KBV_CM_MIO_NFD_Pregnancy_Status_German | Aktueller Schwangerschaftsstatus |
| KBV_CM_Base_Terminology_Complete_German | KBV_CM_Base_Terminology_Complete_German |
| KBV_CM_Base_Apgar_Score_Identifier_German | KBV_CM_Base_Apgar_Score_Identifier_German |
| KBV_CM_Base_Body_Height_Snomed_German | KBV_CM_Base_Body_Height_Snomed_German |
| KBV_CM_Base_Body_Weight_Loinc_German | KBV_CM_Base_Body_Weight_Loinc_German |
| KBV_CM_MIO_LAB_Laboratory_Specialties_German | Laborbereich |
| tiplulaborcodes-loinc | ConceptMap zur Übersetzung von Tiplu Laborcodes in LOINC |
| KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_German |
| KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed | KBV_CM_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_LOINC_Snomed |
| KBV_CM_MIO_MR_Examination_Loinc_German | Laboruntersuchungen |
| twcdc-methoddetails | 檢驗方法細項代碼對應 |
| twcdc-samplingitem | 檢體種類代碼對應 |
| LOINCMaterialToSNOMEDMaterial | LOINCMaterialToSNOMEDMaterial |
| LOINCMethodToSNOMEDMethod | LOINCMethodToSNOMEDMethod |
| loinc-dicom | |
| KBV_CM_MIO_EMP_Overview | KBV_CM_MIO_EMP_Overview |
| severity-loinc-uv-ips | Severity Value Set Mappings - LOINC to FHIR |
| PositieCodelijst-to-LOINC | HCIM PositieCodelijst to LOINC |
| KBV_CM_MIO_TELE_Clinical_Course_German | KBV_CM_MIO_TELE_Clinical_Course_German |
| KBV_CM_MIO_TELE_Procedure_And_Recommendations_German | Weiteres Procedere und Empfehlung |
| ASS-X04-CorrespondanceType-Classe-CISIS | ASS_X04_CorrespondanceType_Classe_CISIS |
| ASS-X16-CorrespondanceType-Classe-DMP | ASS_X16_CorrespondanceType_Classe_DMP |
| StructureDefinition | |
| TipluObservationLaboruntersuchung | Tiplu Observation im Use Case Laboruntersuchung |
| profile-observation-vitals | Observation Vitals Patient Chart |
| ValueSet | |
| well-being-frequency | Well-Being Frequency Answers |
| well-being-satisfaction | Well-Being Satisfaction Answers |
| riap-observaciones-biopsia-VS | Set de Valores para Observaciones Biopsia |
| riap-reporte-biopsia-vs | Set de Valores de los Reportes de Biopsia |
| goal-attainment-scaling-score | Goal Attainment Scaling (GAS) Score |
| prom-target-measures | PROM Target Measure Scores |
| obsCode-loinc-uv-lab | Laboratory Code: LOINC |
| orderCodes-uv-lab | Laboratory Order |
| reportType-uv-lab | Laboratory Report Types |
| studyType-uv-lab | Laboratory Study Types |
| DocumentReferenceCategory | NPFS DocumentReference category |
| vrdr-place-of-injury-vs | Place of Injury ValueSet |
| VSTiposDocClinico | Tipos de Documentos Clínicos |
| cl-core-tipo-reporte | Set de Valores de Tipo de Reporte |
| cl-core-vs-signos-vitales | Set de Valores Signos Vitales |
| cz-lab-report-types-VS | Laboratory Report Types (CZ) |
| cz-lab-study-types-VS | Laboratory Study Types (CZ) |
| ImSectionEmptyReason | Reasons a section in an imaging report is empty. |
| ch-lab-order-study-types | Laboratory Study Types |
| ch-vacd-laboratory-serology-vs | Laboratory Serology for Immunization |
| ValueSet-education-level-person-vr | Value Set - Education Level Person Vital Records |
| testcode-mappings-livd | Test code mappings value set for LIVD |
| at-aps-problems | AT APS Problems |
| LOINCConsentDocumentTypes | LOINC Consent Document Types |
| us-core-diastolic-blood-pressure-code | Vital Signs Diastolic Blood Pressure Codes |
| us-core-mean-arterial-blood-pressure-code | Vital Signs Mean Arterial Blood Pressure Codes |
| us-core-modified-blood-pressure-code | Vital Signs Blood Pressure Codes |
| us-core-pulse-blood-pressure-code | Vital Signs Pulse Blood Pressure Codes |
| us-core-systolic-blood-pressure-code | Vital Signs Systolic Blood Pressure Codes |
| mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set |
| mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set |
| mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set |
| mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set |
| mcode-tumor-marker-test-vs | Tumor Marker Test Value Set |
| holter-event-component-codes | Holter Observation Component Codes |
| holter-report-code | Holter Report Code |
| observation-oct-macula | OCT Macula Observable Entities ValueSet |
| observation-oct-rnfl | OCT RNFL Observable Entities ValueSet |
| VS-GleasonGrade | Gleason Grade |
| ExampleCOVID19TestCodes | Covid-19 Example Test Codes |
| ExampleHbA1cTestCodes | Diabetes Example Test Codes |
| X12278DiagnosisInformationType | X12 278 Diagnosis Information Type |
| pas-loinc-attachment-codes | PAS LOINC Attachment Codes Value Set |
| toc-del-loinc-vs | Transitions of Care DEL LOINC Terms Value Set |
| toc-loinc-answered-by-LL5571-6-vs | Transitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Set |
| mental-health-clinical-note-types | Mental Health Clinical Note Types |
| ch-elm-expecting-organism-specification | CH ELM Expecting Organism Specification |
| ch-elm-expecting-specimen-specification | CH ELM Expecting Specimen Specification |
| ch-elm-lab-study-types | CH ELM Lab Study Types |
| ch-elm-results-component-antibiotic-tb | CH ELM Results Antibiotic Tb |
| ch-elm-results-component-gene-tb | CH ELM Results Gene Tb |
| ch-elm-results-laboratory-observation-complete | CH ELM Results Laboratory Observation Complete |
| ch-elm-results-laboratory-observation-geno | CH ELM Results Laboratory Observation Genotyping |
| ch-elm-results-laboratory-observation-susc | CH ELM Results Laboratory Observation Susceptibility |
| ch-elm-results-laboratory-observation | CH ELM Results Laboratory Observation |
| ihe-ToDo-laughing-positions | The positions during laughing |
| australian-pronouns-1 | Australian Pronouns |
| valueset-calcium-LOINC | LOINC Codes for Serum Calcium |
| valueset-digoxin-LOINC | LOINC Codes for Digoxin Concentration |
| valueset-magnesium-LOINC | LOINC Codes for Serum Potassium |
| valueset-potassium-LOINC | LOINC Codes for Serum Potassium |
| valueset-renal-LOINC | LOINC Codes for Renal Function |
| Antepartum.Laboratory.VS | Antepartum Laboratory |
| pa-diagnosticreport-type | PA DiagnosticReport Types |
| pa-observation-code-activity | PA Observation Activity-related codes |
| pa-observation-code-evs | PA Observation Vital Sign Codes |
| pa-observation-code-time | PA Observation Time-related codes |
| pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| rsg-source-document-type | AU Recorded Sex or Gender (RSG) Source Document Type |
| rsg-type | AU Recorded Sex or Gender Type |
| IHEXDSclassCode | IHE XDS Class Code |
| IHEXDStypeCode | IHE XDS Type Code |
| dna-change-type | LOINC-健保事前審查-基因突變類型值集 |
| gene-test-code | LOINC-健保事前審查-基因檢測代碼值集 |
| pat-ast | LOINC + NHI-健保事前審查-病人狀態評估項目值集 |
| report-type | LOINC-健保事前審查-報告類型值集 |
| specime-type | LOINC-健保事前審查-基因檢測檢體類型值集 |
| ihe-ToDo-laughing-positions | The positions during laughing |
| mcode-observation-codes-distant-metastases-vs | Observation Codes for Distant Metastases Category |
| mcode-observation-codes-primary-tumor-vs | Observation Codes for Primary Tumor Category |
| mcode-observation-codes-regional-nodes-vs | Observation Codes for Regional Node Category |
| smokingStatus-loinc-eu-i4rc | Smoking Status: LOINC |
| dk-ihe-typecode-vs | DK_IHE_TypeCode_VS |
| document-type | Document Type |
| observation-codes | Observation Codes |
| risultato-osservazione | Tipo Osservazione |
| sezione-referto-laboratorio | Sezioni Composition Lab Report |
| pronouns | Personal Pronouns |
| recorded-sex-or-gender-type | Recorded Sex Or Gender Type |
| v3-DocumentSectionType | DocumentSectionType |
| v3-HealthQualityMeasureDocument | HealthQualityMeasureDocument |
| v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| v3-LOINCObservationActContextAgeDefinitionCode | LOINCObservationActContextAgeDefinitionCode |
| v3-LogicalObservationIdentifierNamesAndCodes | LogicalObservationIdentifierNamesAndCodes |
| v3-LoincDocumentOntologyInternational | LoincDocumentOntologyInternational |
| v3-ObservationActContextAgeGroupType | ObservationActContextAgeGroupType |
| v3-QualityMeasureSectionType | QualityMeasureSectionType |
| v3-immunizationForecastDate | immunizationForecastDate |
| TNMStageGroupVS | Staging Type for Stage Group ValueSet |
| eltss-observation-code | Observation Code Value Set |
| valueset-chlamydia-example | Example Chlamydia Lab Obs Test Name Triggers for Public Health Reporting |
| cdex-loinc-attachment-codes | CDex LOINC Attachment Codes Value Set |
| 1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes |
| 2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type |
| 2.16.840.1.113883.1.11.20.2.3 | ReferralDocumentType |
| 2.16.840.1.113883.1.11.20.2.4 | TransferDocumentType |
| 2.16.840.1.113883.1.11.20.22 | HPDocumentType |
| 2.16.840.1.113883.11.20.1.1 | SurgicalOperationNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.4.1 | DischargeSummaryDocumentTypeCode |
| 2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes |
| 2.16.840.1.113883.11.20.8.1 | ProgressNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.9.31 | ConsultDocumentType |
| epiType | ePI document types |
| sectionCode | Section Codes |
| IHE.PCC.APGAR.VS | IHE PCC mPSC APGAR Assessment Type Value Set |
| IHE.PCC.VitalSigns.VS | IHE PCC Vital Signs Value Set |
| IHE.PCC.mPSC.VitalSigns.VS | IHE PCC mPSC Vital Signs Value Set |
| SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT |
| SDOHCC-ValueSetPronounsValue | SDOHCC ValueSet Pronouns Value |
| sdc-profile-example | SDC-ValueSet AHRQ_Medication_Q1 |
| edd-method-uv-ips | Pregnancy Expected Delivery Date Method - IPS |
| pregnancies-summary-uv-ips | Pregnancy Outcome - IPS |
| problem-type-loinc | Problem Type (LOINC) |
| results-laboratory-pathology-observations-uv-ips | Results Laboratory/Pathology Observation - IPS |
| results-radiology-observations-uv-ips | Results Radiology Observation - IPS |
| results-radiology-txtobs-uv-ips | Results Radiology Textual Observation - IPS |
| ADIAttesterRoleTypeVS | Attester Role |
| ADIDocumentationTypeVS | Documentation Types |
| ADIHCADecisionsVS | Healthcare Agent Decisions |
| ADIInterventionPreferencesOrdinalVS | Intervention Preferences - Ordinal |
| LOINCPOLSTCPRAnswerList | LOINC POLST CPR Answer List |
| LOINCPOLSTDiscussPartAnswerList | LOINC POLST discuss part List |
| LOINCPOLSTInitialTxAnswerList | LOINC POLST Initial Tx Answer List |
| LOINCPOLSTMedAssistNutrAnswerList | LOINC POLST Med assist nutr Answer List |
| LOINCPOLSTReviewAnswerList | LOINC POLST review Answer List |
| fetal-rhd-antigen | CH EPREG VS: Fetal RhD Antigen |
| phenotypicFeatureVS | Observation Codes for status of a PhenotypicFeature |
| ImSectionEmptyReason | Reasons a section in an imaging report is empty. |
| LabTestTypeCovid19LoincValueSet | Lab Test - Type - COVID-19 - LOINC |
| LabTestTypeLoincValueSet | Lab Test - Type - Generic - LOINC |
| lab-obsCode-loinc-eu-lab | Laboratory Code: LOINC |
| lab-orderCodes-eu-lab | Laboratory Order |
| lab-reportType-eu-lab | Laboratory Report Types |
| lab-studyType-eu-lab | Laboratory Study Types |
| serviceRequestCodes | CRD Service Request Codes Value Set |
| all-urine-drug-screening-tests | All urine drug screening tests |
| amphetamine-urine-drug-screening-tests | Amphetamine-class drugs and metabolite urine tests |
| barbiturate-urine-drug-screening-tests | Barbiturate urine drug screening tests |
| benzodiazepine-urine-drug-screening-tests | Benzodiazepine urine drug screening tests |
| buprenorphine-urine-drug-screening-tests | Buprenorphine urine drug screening tests |
| cannabinoid-urine-drug-screening-tests | Cannabinoid class urine drug screening |
| cocaine-urine-drug-screening-tests | Cocaine urine drug screening tests |
| fentanyl-type-urine-drug-screening-tests | Fentanyl-type urine drug screening tests |
| general-opiate-urine-drug-screening-tests | General opiate urine drug screening tests |
| heroin-urine-drug-screening-tests | Heroin urine drug screening tests |
| methadone-urine-drug-screening-tests | Methadone urine drug screening tests |
| non-opioid-urine-drug-screening | Non-opioid drug urine screening |
| opiate-specific-urine-drug-screening-tests | Opiate specific urine drug screening tests |
| opioid-urine-drug-screening | Opioid drug urine screening |
| oxycodone-urine-drug-screening-tests | Oxycodone urine drug screening tests |
| pain-treatment-plan | Pain treatment plan |
| phencyclidine-urine-drug-screening-tests | Phencyclidine urine drug screening tests |
| synthetic-opioid-urine-drug-screening-tests | Synthetic opioid urine drug screening tests |
| xylazine-urine-drug-screening-tests | Xylazine drug urine screening tests |
| all-loinc-codes | All LOINC Codes |
| sghi-grade | Grade Value Sets |
| YN | Yes/No |
| YNU | Yes/No/Unknown |
| ethnicity | Ethnicity |
| LL2201-3 | LOINC® LL2201-3 - ValueSet về tình trạng hút thuốc |
| LL3639-3 | LOINC® LL3639-3 - ValueSet về trạng thái lây nhiễm |
| LL3976-9 | LOINC® LL3976-9 - ValueSet về tần suất hút thuốc |
| LL940-8 | LOINC® LL940-8 - ValueSet về tình trạng tiêm chủng |
| observation-codes | LOINC Codes |
| patient-history-social-factor-type | ValueSet dành cho loại tiền sử bệnh lý và đặc điểm xã hội |
| physical-exam-type | ValueSet dành cho loại thăm, khám lâm sàng |
| vn-core-diagnosticreport-code | ValueSet for Diagnostic Report Code |
| BreastImagingReportTypesVS | Breast Imaging Report Types ValueSet |
| pfe-body-structures-vs | Personal Functioning and Engagement Body Structures Value Set |
| pfe-communication-vs | Personal Functioning and Engagement Communication Value Set |
| pfe-domestic-life-vs | Personal Functioning and Engagement Domestic Life Value Set |
| pfe-functions-of-digestive-vs | Personal Functioning and Engagement Functions Of Digestive, Metabolic, and Endocrine Systems Value Set |
| pfe-genitourinary-vs | Personal Functioning and Engagement Genitourinary and Reproductive Functions Value Set |
| pfe-goals-mobility-vs | Personal Functioning and Engagement Goals Mobility Value Set |
| pfe-goals-panel-vs | Personal Functioning and Engagement Goals Panel Value Set |
| pfe-goals-self-care-vs | Personal Functioning and Engagement Goals Self-Care Value Set |
| pfe-learning-and-applying-knowledge-vs | Personal Functioning and Engagement Learning and Applying Knowledge Value Set |
| pfe-mental-functions-vs | Personal Functioning and Engagement Mental Functions Value Set |
| pfe-mobility-vs | Personal Functioning and Engagement Mobility Value Set |
| pfe-neuromusculoskeletal-vs | Personal Functioning and Engagement Neuromusculoskeletal and Movement Related Functions Value Set |
| pfe-panel-vs | Personal Functioning and Engagement Panel Value Set |
| pfe-products-and-technology-vs | Personal Functioning and Engagement Products and Technology Value Set |
| pfe-self-care-vs | Personal Functioning and Engagement Self-Care Value Set |
| pfe-sensory-functions-pain-clinical-test-vs | Personal Functioning and Engagement Sensory Functions and Pain Clinical Test Value Set |
| pfe-sensory-functions-pain-vs | Personal Functioning and Engagement Sensory Functions and Pain Value Set |
| pfe-skin-functions-vs | Personal Functioning and Engagement Functions of Skin and Related Structures Value Set |
| pfe-structures-voice-and-speech-vs | Personal Functioning and Engagement Structures Involved in Voice and Speech Value Set |
| pfe-voice-and-speech-vs | Personal Functioning and Engagement Voice and Speech Functions Value Set |
| sdoh-obs-snomed-loinc-eu-hdr | SDOH Observation codes |
| bdr-eventtypes | Birth Defect Report Event Types |
| condition-severity-uv-ips | Problem Severity |
| pregnancies-summary-uv-ips | IPS Pregnancies Summary |
| 2.16.840.1.113883.11.22.37--20170523000000 | IPS Results Organizer |
| observation-codes-uv-ips | IPS Results Observation |
| imaging-observations-uv-ips | IPS Results Radiology Observation |
| 2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations |
| 2.16.840.1.113883.11.22.72--20240802094107 | IPS Pregnancy Expected Delivery Date Method |
| apix-document-type | APIX Document Type Value Set |
| ch-lab-bloodgroup-antibody-screen-vs | CH LAB-Report BloodGroup Antibody Screen Test (LOINC codes) |
| observation-code-cdk-epi-2009 | CH LAB-Report Codes for eGFR in CKD-EPI |
| observation-code-cdk-epi-2021 | CH LAB-Report Codes for eGFR in CKD-EPI 2021 |
| observation-code-entsvol-ratio | CH LAB-Report Codes for Erythrocyte Distribuiton Width Test |
| observation-code-mdrd-male-female | CH LAB-Report Codes for eGFR (MDRD) |
| CardiacCTA | CTA Heart and Coronary arteries |
| ChronicLungDisease | Chronic Lung Disease |
| FamilyPrematureCAD | Family History of Premature CAD |
| NewYorkHeartAssociation | New York Heart Association Assessment Scale |
| NewYorkHeartAssociationAnswers | New York Heart Association OA Answer List |
| PriorCABG | Prior History of Coronary Artery Bypass Graft |
| RoseDyspneaQ | Rose Dyspnea Questions |
| SEattleAnginaQs | Seattle Angina Questions |
| SeattleAnginaAs | Seattle Angina Answers |
| StressTest | Cath PCI Selected Stress Test |
| ValvularStenosis | Valvular Stenosis |
| sensitive-care-team-codes | ValueSet - Sensitive CareTeam Codes |
| sensitive-condition-codes | ValueSet - Sensitive Condition Codes |
| sensitive-observation-codes | ValueSet - Sensitive Observation Codes |
| loinc-doc-section-code | LOINC Code Document Section值集 |
| loinc-document-classcodes | LOINC Document Class值集 |
| loinc-observation-code | LOINC實驗室檢驗檢查值集 |
| loinc-pregnancy-intent-code | LOINC + HL7 NullFlavor妊娠計畫值集 |
| loinc-survey-codes | LOINC篩檢與評估值集 |
| loinc-type-doc-code | LOINC Code Document Type值集 |
| smoking-status-type-code | SNOMED CT + LOINC 吸菸狀態種類向值集 |
| vital-signs-tw | LOINC生命體徵值集 |
| YN | Yes/No |
| YNU | Yes/No/Unknown |
| ethnicity | Ethnicity |
| splDocumentCodes | SPL Document Codes |
| splSectionCodes | SPL Section Codes |
| valueset-genericFacilityMessageTypes | Generic Facility Message Types |
| valueset-organizationSubmissionMessageTypes | Organization Submission Message Types |
| ValueSet-apgar-timing | APGAR Score Timing |
| cigarette-smoking-before-during-pregnancy | Cigarette Smoking Before and During Pregnancy |
| TNMStageGroupVS | Staging Type for Stage Group ValueSet |
| us-core-clinical-note-type | US Core Clinical Note Type |
| us-core-diagnosticreport-category | US Core Diagnostic Report Category Codes |
| us-core-diagnosticreport-report-and-note-codes | US Core Non Laboratory Codes |
| us-core-documentreference-type | US Core DocumentReference Type |
| us-core-goal-description | US Core Goal Codes |
| us-core-laboratory-test-codes | US Core Laboratory Test Codes |
| us-core-procedure-code | US Core Procedure Codes |
| dna-change-type | LOINC-健保NGS-基因突變類型值集 |
| gene-test-code | LOINC-健保NGS-基因檢測代碼值集 |
| specime-type | LOINC-健保NGS-基因檢測檢體類型值集 |
| cigarette-smoking-before-during-pregnancy | Cigarette Smoking Before and During Pregnancy |
| Ab-det-past-recent-infection-vs | Antibody Not Detected, Past/Recent Infection LOINC answer value set. |
| covid19-detected-genetic-mutation-la-codes-value-set | Detected Genetic Mutations LOINC answer codes value set |
| covid19-who-path-la-codes-value-set | World Health Organization, COVID-19 variant LOINC answer code value set |
| exposure-type-la-value-set | Exposure Type LOINC Answer Value Set |
| sars-cov2-clade-loinc-answer-value-set | SARS CoV 2 Clade Assignment LOINC Answer value set |
| sars-cov2-lineage-loinc-answer-value-set | SARS CoV 2 Lineage LOINC Answers |
| sars-cov2-rdrp-mutation-vs | SARS CoV 2 RdRp Gene Mutation value set |
| StdLabObsCoded-value-set | Standard Coded Lab Observation Code value set |
| StdLabObsOrdinal-value-set | Standard Coded Ordinal Lab Observation Code value set |
| loinc-doc-value-set | LOINC Document class value set |
| standard-lab-obs-narrative-value-set | Standard Lab Obs Narrative value set |
| standard-lab-obs-quantitative-value-set | Standard Lab Obs Quantitative Code value set |
| titer-lab-codes-value-set | Titer Lab Codes value set |
| dataelement-sdcobjectclass | DataElement SDC Object Class |
| dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| ihe-ToDo-laughing-positions | The positions during laughing |
| IMMZ.Z.DE11 | IMMZ.Z.DE11 ValueSet for Mumps-containing vaccines |
| IMMZ.Z.DE17 | IMMZ.Z.DE17 ValueSet for Rubella-containing vaccines |
| IMMZ.Z.DE3 | IMMZ.Z.DE3 ValueSet for Diphtheria-containing vaccines |
| IMMZ.Z.DE32 | IMMZ.Z.DE32 ValueSet for Measles and rubella-containing vaccines |
| IMMZ.Z.DE4 | IMMZ.Z.DE4 ValueSet for Hib-containing vaccines |
| IMMZ.Z.DE6 | IMMZ.Z.DE6 ValueSet for Hepatitis B-containing vaccines |
| IMMZ.Z.DE9 | IMMZ.Z.DE9 ValueSet for Measles-containing vaccines |
| genetic-therapeutic-implications-vs | Genetic Therapeutic Implications |
| molecular-biomarker-code-vs | Molecular Biomarker Codes |
| DocumentLOINCCodelist | Document Class & Type waardelijst |
| NDHCareTeamCategoryVS | NDH Care Team Category Value Set |
| pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| Covid19Labs | COVID-19 Diagnostic Test |
| PatientsOnVentilator | Observations for Patients on a Ventilator |
| SARSCoV2GeneticLabs | SARSCoV2 Genetic Labs |
| SARSCoV2Labs | SARS CoV2 Labs |
| VTEReports | Codes for reports about VTE Diagnosics |
| VentilatorObservations | Ventilator Observations |
| loinc-report-type | LOINC-健保重大傷病-報告類型值集 |
| YN | Yes/No |
| YNU | Yes/No/Unknown |
| ethnicity | Ethnicity |
| Antepartum.Laboratory.VS | Antepartum Laboratory |
| argonaut-clinical-note-type | Argonaut DocumentReferences Type Value Set |
| diagnosticreport-category | Argonaut DiagnosticReport Category Value Set |
| ISiKSpecificGenericTempLoincVS | ISiK Specific Generische Koerpertemperatur LOINC Konzepte |
| ISiKSpecificKernTempLoincVS | ISiK Specific Kerntemperatur LOINC ValueSet |
| ObservationCodesCRP | ObservationCodesCRP |
| ObservationCodesGFR | ObservationCodesGFR |
| ObservationCodesHb | ObservationCodesHb |
| ObservationCodesPCT | ObservationCodesPCT |
| ObservationCodesSerumkreatinin | ObservationCodesSerumkreatinin |
| ObservationCodesTSH | ObservationCodesTSH |
| ObservationCodesThrombozyten | ObservationCodesThrombozyten |
| ObservationCodesTroponin | ObservationCodesTroponin |
| SchwangerschaftEtMethodeVS | Schwangerschaft Erwarteter Entbindungstermin Methode |
| SchwangerschaftsstatusVS | Schwangerschaftsstatus Valueset |
| StillstatusVS | Stillstatus LOINC Antwortoptionen |
| current-smoking-status-uv-ips | Current Smoking Status - IPS |
| vs-mii-icu-code-monitoring-und-vitaldaten-loinc | VS MII ICU Code Monitoring und Vitaldaten [LOINC] |
| mii-vs-mikrobio-barlett-score-loinc | MII VS Mikrobio Barlett Score [LOINC] |
| mii-vs-mikrobio-befundtyp-loinc | MII VS Mikrobio Befundtyp [LOINC] |
| mii-vs-mikrobio-empfindlichkeit-genotyp-loinc | MII VS Mikrobio Empfänglichkeit Genotyp [LOINC] |
| mii-vs-mikrobio-empfindlichkeit-phenotyp-loinc | MII VS Mikrobio Empfindlichkeit Phenotyp [LOINC] |
| mii-vs-mikrobio-keimzahl-loinc | MII VS Mikrobio Keimzahl [LOINC] |
| mii-vs-mikrobio-kulturtests-loinc | MII VS Mikrobio Kulturtests [LOINC] |
| mii-vs-mikrobio-mikroskopie-tests-loinc | MII VS Mikrobio Mikroskopie Tests [LOINC] |
| mii-vs-mikrobio-molekulare-diagnostik-loinc | MII VS Mikrobio Molekulare Diagnostik [LOINC] |
| mii-vs-mikrobio-mrgn-klasse-loinc | MII VS Mikrobio MRGN Klasse [LOINC] |
| mii-vs-mikrobio-resistenzgene-loinc | MII VS Mikrobio Resistenzgene [LOINC] |
| mii-vs-mikrobio-resistenzmutation-loinc | MII VS Mikrobio Resistenzmutation [LOINC] |
| mii-vs-mikrobio-serologie-immunologie-loinc | MII VS Mikrobio Serologie Immunologie [LOINC] |
| mii-vs-mikrobio-virulenz-loinc | MII VS Mikrobio Virulenz [LOINC] |
| document-ontology-part-type | Document Ontology Part Type EHR |
| epa-medication-management-note-vs | EPA Medication Management Note ValueSet |
| KBV_VS_MIO_NFD_Pregnancy_Status | Aktueller Schwangerschaftsstatus |
| Wundheilungsphasen | Wundheilungsphasen |
| contentVerbalAssessment | PosiThera - Inhalte verbaler Angaben |
| mii-vs-patho-all-loinc | MII VS Patho All [LOINC] |
| mii-vs-patho-composition-type-loinc | MII VS Patho Composition Type [LOINC] |
| mii-vs-patho-section-types-loinc | MII VS Patho Section Types [LOINC] |
| NICE-LaboratoryTestResultCodelist | NICE Laboratory Test Results |
| KBV_VS_Base_Apgar_Score_Identifier_LOINC | Apgar Score LOINC® |
| KBV_VS_Base_Breastfeeding_Status_LOINC | Stillzeitstatus LOINC® |
| KBV_VS_Base_Estimated_Date_of_Delivery_LOINC | Geschätzter Entbindungstermin LOINC® |
| KBV_VS_Base_Glucose_Concentration_LOINC | Blutzucker LOINC® |
| KBV_VS_Base_Pregnancy_Status_LOINC | Aktueller Schwangerschaftsstatus LOINC® |
| KBV_VS_Base_Apgar_Score_Identifier_Loinc | KBV_VS_Base_Apgar_Score_Identifier_Loinc |
| KBV_VS_Base_Body_Height_Loinc | Koerpergroesse |
| KBV_VS_Base_Body_Weight_Loinc | Loinccodes für die Koerpergroesse |
| sdc-profile-example | AHRQ Medication Q1 |
| type-document-reference-esms-valueset | DocumentReferenceTypeESMSValueSet |
| demog-alert-code | Demog Alert Code |
| composition-form-type-my-core | ValueSetCompositionFormType (MY Core) |
| loinc-my-core | ValueSetLoinc (MY Core) |
| observation-anthropometry-my-core | ValueSetObservationAnthropometry (MY Core) |
| observation-obstetric-us-my-core | ValueSetObservationObstetricUs (MY Core) |
| observation-panel-my-core | ValueSetObservationPanel (MY Core) |
| observation-vital-signs-my-core | ValueSetObservationVitalSigns (MY Core) |
| observation-vsc-bp-my-core | ValueSetObservationVSCBP (MY Core) |
| observation-vsc-hr-my-core | ValueSetObservationVSCHR (MY Core) |
| observation-vsc-so2-my-core | ValueSetObservationVSCSO2 (MY Core) |
| observation-vsc-t-my-core | ValueSetObservationVSCT (MY Core) |
| PocLisCodigoTest | PocLisCodigoTest |
| nfdi4health-vs-mds-time-units-ucum-loinc | NFDI4Health VS MDS Provenance Time Units [UCUM, LOINC] |
| KBV_VS_MIO_LAB_Laboratory_Specialties | Laborbereich |
| LL1023-2 | [PROMIS] Very poor|Poor|Fair|Good|Very good |
| LL2335-9 | Numeric rating scale from 0-10 |
| yesno | Yesno |
| sdohObservationCode | SDOH Observation Code |
| EkgLeads | EKG/ECG leads |
| VitalSignDE_Body_Height_Loinc | ValueSetVitalSignDE_Body_Height_Loinc |
| glasgow-coma-score-eye | VS Score Glasgow Coma Score Eye |
| glasgow-coma-score-motor | VS Score Glasgow Coma Score Motor |
| glasgow-coma-score-verbal | VS Score Glasgow Coma Score Verbal |
| TipluUnterstuetzteLaboratoryLoincCodesVS | ValueSet der von Tiplu unterstützten LOINC Codes |
| KBV_VS_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence | Titerbezeichnung |
| oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet |
| oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet |
| oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet |
| oncology-HER2byIHCScoreVS | BC HER2byIHCScoreVS ValueSet |
| oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet |
| bc-BirthObservation-code | bc-BirthObservation-code |
| bc-ChildObservation-code | bc-ChildObservation-code |
| bc-DeliveryObservation-code | bc-DeliveryObservation-code |
| bc-FetusObservation-code | bc-FetusObservation-code |
| bc-MaternalObservation-code | bc-MaternalObservation-code |
| bc-PregnancyObservation-code | bc-PregnancyObservation-code |
| exame | Exame |
| loinc-observation-clinical-code | LOINC臨床分類值集 |
| KBV_VS_MIO_MR_Examination_Loinc | Laboruntersuchungen |
| MaiaUnterstuetzteLoincCodes | ValueSet der von Maia unterstützten LOINC Codes |
| MaiaUnterstuetzteVitalparameterUndMesserteVS | ValueSet der von Maia unterstützten Vitalparameter und Messwerte |
| composition-form-type-id-core | ValueSetCompositionFormType (ID Core) |
| loinc-id-core | ValueSetLoinc (ID Core) |
| observation-anthropometry-id-core | ValueSetObservationAnthropometry (ID Core) |
| observation-obstetric-us-id-core | ValueSetObservationObstetricUs (ID Core) |
| observation-panel-id-core | ValueSetObservationPanel (ID Core) |
| observation-vital-signs-id-core | ValueSetObservationVitalSigns (ID Core) |
| observation-vsc-bp-id-core | ValueSetObservationVSCBP (ID Core) |
| observation-vsc-hr-id-core | ValueSetObservationVSCHR (ID Core) |
| observation-vsc-so2-id-core | ValueSetObservationVSCSO2 (ID Core) |
| observation-vsc-t-id-core | ValueSetObservationVSCT (ID Core) |
| HDBP0037-TestCode | HDBP0037-TestCode |
| 2.16.840.1.113883.2.4.3.11.60.140.11.14--20240226140032 | FACIT LL5215-0 (Not at all=0, Very much=4 ) |
| 2.16.840.1.113883.2.4.3.11.60.140.11.9--20240220101531 | Numeric Pain Rating Scale Answer List (LL2335-9) |
| tnm-klassifikation-typ-loinc | ValueSet TNM Klassification Typ LOINC |
| tnm-m-kategorie-typ-loinc | ValueSet TNM M-Kategorie Typ LOINC |
| tnm-n-kategorie-typ-loinc | ValueSet TNM N-Kategorie Typ LOINC |
| tnm-t-kategorie-typ-loinc | ValueSet TNM T-Kategorie Typ LOINC |
| doc-typecodes | ReferralDocumentType |
| JDV-J07-XdsTypeCode-CISIS | JDV_J07-XdsTypeCode-CISIS |
| JDV-J154-TypeGlucose-ENS | JDV_J154-TypeGlucose-ENS |
| JDV-J157-MomentGlucose-ENS | JDV_J157-MomentGlucose-ENS |
| JDV-J279-Loinc-UPNOS | JDV_J279-Loinc-UPNOS |
| JDV-J66-TypeCode-DMP | JDV_J66-TypeCode-DMP |
| krcore-vital-signs-codes | KR Core Vital Signs Codes |
| vs-mii-icu-code-monitoring-und-vitaldaten-loinc | VS MII ICU Code Monitoring und Vitaldaten [LOINC] |
| vs-mii-icu-code-observation-beatmung-loinc | VS MII ICU Code Observation Beatmung [LOINC] |
| vs-mii-icu-code-observation-bilanzen-loinc | VS MII ICU Code Observation Bilanzen [LOINC] |
| vs-mii-icu-code-observation-extrakorporale-verfahren-loinc | VS MII ICU Code Observation extrakorporale Verfahren [LOINC] |
| loinc-method-details-values | LOINC檢驗方法值集 |
| loinc-observation-category | LOINC實驗室檢驗檢查類型值集 |
| twcdc-loinc-code-values | CDC-LOINC實驗室通報項目值集 |
| answerSetLaboratoryTest-LOINC | LOINC-AnswerSet für Labortest |
| answerSetResistance-LOINC | LOINC-AnswerSet für Resistenz |
| laboratoryTestABVP | Labortest für Arboviren (sonstige) |
| laboratoryTestACBP | Labortest für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| laboratoryTestADEP | Labortest für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
| laboratoryTestADVP | Labortest für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
| laboratoryTestASTP | Labortest für Astroviren |
| laboratoryTestBANP | Labortest für Bacillus anthracis |
| laboratoryTestBOBP | Labortest für (Lyme-) Borreliose, Borrelia burgdorferi |
| laboratoryTestBORP | Labortest für Borrelia recurrentis |
| laboratoryTestBOVP | Labortest für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
| laboratoryTestBPSP | Labortest für Bordetella pertussis, Bordetella parapertussis |
| laboratoryTestBRUP | Labortest für Brucella sp. |
| laboratoryTestCAMP | Labortest für Campylobacter spp. (darmpathogen) |
| laboratoryTestCAUP | Labortest für Candida auris; Meldepflicht nur für den direkten Nachweis |
| laboratoryTestCHLP | Labortest für Chlamydia psittaci |
| laboratoryTestCKVP | Labortest für Chikungunya-Virus |
| laboratoryTestCLOP | Labortest für Clostridium botulinum oder Toxinnachweis |
| laboratoryTestCLTP | Labortest für Tetanus, Clostridium tetani |
| laboratoryTestCORP | Labortest für Corynebacterium spp. (Toxin bildend) |
| laboratoryTestCOXP | Labortest für Coxiella burnetii |
| laboratoryTestCRYP | Labortest für humanpathogene Cryptosporidium sp. |
| laboratoryTestCVDP | Labortest für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
| laboratoryTestCVSP | Labortest für Severe-Acute-Respiratory-Syndrome-Coronavirus-1 (SARS-CoV-1) (2003) |
| laboratoryTestCYMP | Labortest für Cytomegalie, Cytomegalievirus |
| laboratoryTestDENP | Labortest für Denguevirus |
| laboratoryTestEAHP | Labortest für Amoebiasis, Entamoeba histolytica |
| laboratoryTestEBCP | Labortest für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| laboratoryTestEBVP | Labortest für Ebolavirus |
| laboratoryTestECOP | Labortest für Escherichia coli (sonstige darmpathogene Stämme) |
| laboratoryTestEHCP | Labortest für Escherichia coli (enterohämorrhagische Stämme) (EHEC) |
| laboratoryTestETVP | Labortest für Enteroviren |
| laboratoryTestFRTP | Labortest für Francisella tularensis |
| laboratoryTestFSVP | Labortest für FSME-Virus |
| laboratoryTestGBSP | Labortest für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
| laboratoryTestGFVP | Labortest für Gelbfiebervirus |
| laboratoryTestGILP | Labortest für Giardia lamblia |
| laboratoryTestHAVP | Labortest für Hepatitis-A-Virus |
| laboratoryTestHBVP | Labortest für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| laboratoryTestHCVP | Labortest für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| laboratoryTestHDVP | Labortest für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
| laboratoryTestHEVP | Labortest für Hepatitis-E-Virus |
| laboratoryTestHFAP | Labortest für Andere Erreger hämorrhagischer Fieber |
| laboratoryTestHINP | Labortest für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
| laboratoryTestHTVP | Labortest für Hantavirus |
| laboratoryTestINVP | Labortest für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
| laboratoryTestLEGP | Labortest für Legionella sp. |
| laboratoryTestLEPP | Labortest für humanpathogene Leptospira sp. |
| laboratoryTestLISP | Labortest für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
| laboratoryTestLSVP | Labortest für Lassavirus |
| laboratoryTestMBVP | Labortest für Marburgvirus |
| laboratoryTestMPMP | Labortest für Mycoplasmen |
| laboratoryTestMPVP | Labortest für Mumpsvirus |
| laboratoryTestMPXP | Labortest für Orthopockenviren (Mpoxvirus) |
| laboratoryTestMRAP | Labortest für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
| laboratoryTestMRSP | Labortest für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
| laboratoryTestMSVP | Labortest für Masernvirus |
| laboratoryTestMYLP | Labortest für Mycobacterium leprae |
| laboratoryTestMYTP | Labortest für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
| laboratoryTestNCVP | Labortest für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| laboratoryTestNEIP | Labortest für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten |
| laboratoryTestNOVP | Labortest für Norovirus |
| laboratoryTestOPXP | Labortest für Orthopockenviren (sonstige Orthopockenviren) |
| laboratoryTestPINP | Labortest für Parainfluenzavirus |
| laboratoryTestPKVP | Labortest für Orthopockenviren (Variolavirus) |
| laboratoryTestPLAP | Labortest für Plasmodium spp. (Malaria) |
| laboratoryTestPOVP | Labortest für Poliovirus |
| laboratoryTestPVBP | Labortest für Ringelröteln, Parvovirus B 19 |
| laboratoryTestRBVP | Labortest für Rabiesvirus |
| laboratoryTestRICP | Labortest für Rickettsia prowazekii |
| laboratoryTestRSVP | Labortest für Respiratorisches-Synzytial-Virus |
| laboratoryTestRTVP | Labortest für Rotavirus |
| laboratoryTestRUVP | Labortest für Rubellavirus |
| laboratoryTestSALP | Labortest für Salmonella (sonstige) |
| laboratoryTestSHIP | Labortest für Shigella sp. |
| laboratoryTestSPAP | Labortest für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise |
| laboratoryTestSPNP | Labortest für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten |
| laboratoryTestSPYP | Labortest für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A |
| laboratoryTestSTYP | Labortest für Salmonella Typhi; Meldepflicht für alle direkten Nachweise |
| laboratoryTestTRIP | Labortest für Trichinella spiralis |
| laboratoryTestVCHP | Labortest für Vibrio cholerae |
| laboratoryTestVZVP | Labortest für Varizella-Zoster-Virus |
| laboratoryTestWBKP | Labortest für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
| laboratoryTestWNVP | Labortest für West-Nil-Virus |
| laboratoryTestYENP | Labortest für Yersinia spp. (darmpathogen) |
| laboratoryTestYPSP | Labortest für Yersinia pestis |
| laboratoryTestZKVP | Labortest für Zika-Virus |
| resistance | Resistenz |
| resistanceGene | Resistenzdeterminante |
| VSTiposDocClinic | Tipos de Documentos Clínicos |
| elga-antibiogramm | ELGA_Antibiogramm |
| elga-laborparameter | ELGA_Laborparameter |
| elga-pregnanciessummary | ELGA_PregnanciesSummary |
| elga-pregnancystatus | ELGA_PregnancyStatus |
| elga-vitalparameterarten | ELGA_Vitalparameterarten |
| bp-components | Blood Pressure component codes |
| il-core-document-type | IL Core Document Type codes |
| il-core-observation-code | IL Core Observation Codes |
| il-core-observation-lab-code | IL Core Observation Lab Code |
| il-core-observation-value | IL Core Observation Value Codes |
| il-core-procedure-code | IL Core procedure Codes |
| loinc-rsna-radiology-playbook | ImagingProcedureCode |
| answerSetResistance | AnswerSet für Resistenz |
| laboratoryTestHFMP | Labortest für Hand-Fuß-Mund-Krankheit |
| pronouns | Person Pronouns |
| recordedgendertype | Recorded Gender Type Value Set |
| recordedgender | Recorded Gender Value Set |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20200901000000 | AdemhalingScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20200901000000 | AlertTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.2--20200901000000 | HartslagScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.4--20200901000000 | HuidskleurScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.5--20200901000000 | OnderzoekCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.5--20200901000000 | ReflexenScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.3--20200901000000 | SpierspanningScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20200901000000 | TestCodeLOINCCodelijst |
| dk-core-LoincBasicObservation | DK Core LOINC Basic Observations |
| mcode-observation-codes-distant-metastases-vs | Observation Codes for Distant Metastases Category |
| mcode-observation-codes-primary-tumor-vs | Observation Codes for Primary Tumor Category |
| mcode-observation-codes-regional-nodes-vs | Observation Codes for Regional Node Category |
| mcode-observation-codes-stage-group-vs | Observation Codes for Stage Group Category |
| vs-docref-doctype-eu-pcsp | Document Type |
| mii-vs-mtb-molekulare-biomarker | MII VS Molekulare Biomarker |
| mii-vs-mtb-mmr-expression | MII VS Mismatch Repair Proteins Expression |
| mii-vs-mtb-msi | MII VS Mikrosatelliteninstabilität |
| ValueSet-Nombres-Examenes-LOINC | LOINC Value Set de Nombres de Exámenes |
| EMDAF_VS_Laborparameter | EMDAF_VS_Laborparameter |
| sect_CID_100.html | QuantitativeDiagnosticImagingProcedure |
| sect_CID_10046.html | GFRMeasurement |
| sect_CID_101.html | ImagingProcedure |
| sect_CID_109.html | DiagnosticImagingProcedurewithIVContrast |
| sect_CID_12003.html | OBGYNDate |
| sect_CID_12004.html | FetalBiometryRatio |
| sect_CID_12005.html | FetalBiometryMeasurement |
| sect_CID_12006.html | FetalLongBonesBiometryMeasurement |
| sect_CID_12007.html | FetalCraniumMeasurement |
| sect_CID_12008.html | OBGYNAmnioticSacMeasurement |
| sect_CID_12009.html | EarlyGestationBiometryMeasurement |
| sect_CID_12011.html | UltrasoundPelvisandUterusMeasurement |
| sect_CID_12012.html | OBEquation/Table |
| sect_CID_12013.html | GestationalAgeEquation/Table |
| sect_CID_12014.html | OBFetalBodyWeightEquation/Table |
| sect_CID_12015.html | FetalGrowthEquation/Table |
| sect_CID_12016.html | EstimatedFetalWeightPercentileEquation/Table |
| sect_CID_12018.html | OBGYNSummary |
| sect_CID_12019.html | OBGYNFetusSummary |
| sect_CID_12024.html | VascularUltrasoundReportDocumentTitle |
| sect_CID_12100.html | VascularUltrasoundReportDocumentTitle |
| sect_CID_12119.html | VascularUltrasoundProperty |
| sect_CID_12120.html | UltrasoundBloodVelocityMeasurement |
| sect_CID_12121.html | VascularIndex/Ratio |
| sect_CID_12122.html | OtherVascularProperty |
| sect_CID_12123.html | CarotidRatio |
| sect_CID_12124.html | RenalRatio |
| sect_CID_12200.html | EchocardiographyLeftVentricleMeasurement |
| sect_CID_12201.html | LeftVentricleLinearMeasurement |
| sect_CID_12202.html | LeftVentricleVolumeMeasurement |
| sect_CID_12203.html | LeftVentricleOtherMeasurement |
| sect_CID_12204.html | EchocardiographyRightVentricleMeasurement |
| sect_CID_12205.html | EchocardiographyLeftAtriumMeasurement |
| sect_CID_12206.html | EchocardiographyRightAtriumMeasurement |
| sect_CID_12207.html | EchocardiographyMitralValveMeasurement |
| sect_CID_12208.html | EchocardiographyTricuspidValveMeasurement |
| sect_CID_12209.html | EchocardiographyPulmonicValveMeasurement |
| sect_CID_12210.html | EchocardiographyPulmonaryArteryMeasurement |
| sect_CID_12211.html | EchocardiographyAorticValveMeasurement |
| sect_CID_12212.html | EchocardiographyAortaMeasurement |
| sect_CID_12214.html | EchocardiographyPulmonaryVeinMeasurement |
| sect_CID_12215.html | EchocardiographyVenaCavaMeasurement |
| sect_CID_12216.html | EchocardiographyHepaticVeinMeasurement |
| sect_CID_12217.html | EchocardiographyCardiacShuntMeasurement |
| sect_CID_12218.html | EchocardiographyCongenitalAnomalyMeasurement |
| sect_CID_12220.html | EchocardiographyCommonMeasurement |
| sect_CID_12222.html | OrificeFlowProperty |
| sect_CID_12250.html | CardiacUltrasoundCommonLinearMeasurement |
| sect_CID_12251.html | CardiacUltrasoundLinearValveMeasurement |
| sect_CID_12252.html | CardiacUltrasoundCardiacFunction |
| sect_CID_12253.html | CardiacUltrasoundAreaMeasurement |
| sect_CID_12254.html | CardiacUltrasoundHemodynamicMeasurement |
| sect_CID_12255.html | CardiacUltrasoundMyocardiumMeasurement |
| sect_CID_12257.html | CardiacUltrasoundLeftVentricleMeasurement |
| sect_CID_12258.html | CardiacUltrasoundRightVentricleMeasurement |
| sect_CID_12259.html | CardiacUltrasoundVentriclesMeasurement |
| sect_CID_12260.html | CardiacUltrasoundPulmonaryArteryMeasurement |
| sect_CID_12261.html | CardiacUltrasoundPulmonaryVein |
| sect_CID_12262.html | CardiacUltrasoundPulmonaryValveMeasurement |
| sect_CID_12263.html | CardiacUltrasoundVenousReturnPulmonaryMeasurement |
| sect_CID_12264.html | CardiacUltrasoundVenousReturnSystemicMeasurement |
| sect_CID_12265.html | CardiacUltrasoundAtriaandAtrialSeptumMeasurement |
| sect_CID_12266.html | CardiacUltrasoundMitralValveMeasurement |
| sect_CID_12267.html | CardiacUltrasoundTricuspidValveMeasurement |
| sect_CID_12268.html | CardiacUltrasoundAtrioventricularValveMeasurement |
| sect_CID_12269.html | CardiacUltrasoundInterventricularSeptumMeasurement |
| sect_CID_12270.html | CardiacUltrasoundAorticValveMeasurement |
| sect_CID_12271.html | CardiacUltrasoundOutflowTractMeasurement |
| sect_CID_12272.html | CardiacUltrasoundSemilunarValve,AnnulateandSinusMeasurement |
| sect_CID_12273.html | CardiacUltrasoundAorticSinotubularJunctionMeasurement |
| sect_CID_12274.html | CardiacUltrasoundAortaMeasurement |
| sect_CID_12275.html | CardiacUltrasoundCoronaryArteryMeasurement |
| sect_CID_12276.html | CardiacUltrasoundAortoPulmonaryConnectionMeasurement |
| sect_CID_12277.html | CardiacUltrasoundPericardiumandPleuraMeasurement |
| sect_CID_12279.html | CardiacUltrasoundFetalGeneralMeasurement |
| sect_CID_12300.html | CoreEchoMeasurement |
| sect_CID_12304.html | CardiovascularMeasuredProperty |
| sect_CID_12314.html | CommonFetalEchocardiographyMeasurements |
| sect_CID_12320.html | GeneralUltrasoundReportDocumentTitle |
| sect_CID_12333.html | StructuralHeartMeasurement |
| sect_CID_12337.html | StructuralHeartEchoMeasurement |
| sect_CID_3441.html | PatientAssessment |
| sect_CID_3455.html | IndexMethod |
| sect_CID_3467.html | EjectionFraction |
| sect_CID_3468.html | EDVolume |
| sect_CID_3469.html | ESVolume |
| sect_CID_3524.html | BloodGasPressure |
| sect_CID_3525.html | BloodGasContent |
| sect_CID_3526.html | BloodGasSaturation |
| sect_CID_3527.html | BloodBaseExcess |
| sect_CID_3528.html | BloodpH |
| sect_CID_3529.html | Arterial/VenousContent |
| sect_CID_3611.html | PressureMeasurement |
| sect_CID_3620.html | HemodynamicRatio |
| sect_CID_3833.html | CardiacEjectionFraction |
| sect_CID_3835.html | CardiacVolumeMeasurement |
| sect_CID_4110.html | TracerKineticModelingCovariate |
| sect_CID_6050.html | BreastProcedureReported |
| sect_CID_6052.html | BreastImagingReportSectionTitle |
| sect_CID_6053.html | BreastImagingReportElement |
| sect_CID_6083.html | ProceduresforBreast |
| sect_CID_6352.html | ProstateCancerDiagnosticBloodLabMeasurement |
| sect_CID_646.html | PreclinicalSmallAnimalImagingProcedure |
| sect_CID_7000.html | DiagnosticImagingReportDocumentTitle |
| sect_CID_7001.html | DiagnosticImagingReportHeading |
| sect_CID_7002.html | DiagnosticImagingReportElement |
| sect_CID_7061.html | ModelDocumentTitle |
| sect_CID_7448.html | ThirdPersonPronounSet |
| sect_CID_9509.html | PurposeofReferenceforRTPhysicianIntentInput |
| cyehr-vs-ehdsibloodpressure | Cyprus EHR Value Set: eHDSI Blood Pressure |
| cyehr-vs-ehdsidocumentcode | Cyprus EHR Value Set: eHDSI DocumentCode |
| cyehr-vs-ehdsihospitaldischargereporttype | Cyprus EHR Value Set: eHDSI Hospital Discharge Report Type |
| cyehr-vs-ehdsilaboratoryreporttype | Cyprus EHR Value Set: eHDSI Laboratory Report Type |
| cyehr-vs-ehdsimedicalimagestype | Cyprus EHR Value Set: eHDSI Medical Images Type |
| cyehr-vs-ehdsimedicalimagingreporttype | Cyprus EHR Value Set: eHDSI Medical Imaging Report Type |
| cyehr-vs-ehdsipregnancyinformation | Cyprus EHR Value Set: eHDSI Pregnancy Information |
| cyehr-vs-ehdsisection | Cyprus EHR Value Set: eHDSI Section |
| cyehr-vs-exercise | Cyprus EHR Value Set: Exercise |
| cyehr-vs-tobaccostatus | Cyprus EHR Value Set: Tobacco Status |
| cyehr-vs-exerciseintensity | Cyprus EHR Value Set: Exercise Intensity |
| cyehr-vs-diagnosiscategory | Cyprus EHR Value Set: Diagnosis Category |
| fiphr-vs-exerciseintensity | Value Set Finnish PHR Exercise Intensity |
| fiphr-vs-exercisetracking | Value Set Finnish PHR Exercise Tracking |
| fiphr-vs-fitnessresult | Value Set Finnish PHR Fitness Results |
| fiphr-vs-macronutrients | Value Set Finnish PHR Macronutrients |
| fiphr-vs-metbystandardrmr | Value Set Finnish PHR MET by Standard RMR |
| fiphr-vs-nutrition | Value Set Finnish PHR Nutrition |
| fiphr-vs-sourceforadjustedmet | Value Set Finnish PHR Source for Adjusted MET |
| fiphr-vs-sourceforestimatedmet | Value Set Finnish PHR Source for Estimated MET |
| fiphr-vs-sourceforreportedmet | Value Set Finnish PHR Source for Reported MET |
| fiphr-vs-vitalsigns | Value Set Finnish PHR Vital Signs |
| pronouns | Personal Pronouns |
| recorded-sex-or-gender-type | Recorded Sex Or Gender Type |
| v3-DocumentSectionType | DocumentSectionType |
| v3-HealthQualityMeasureDocument | HealthQualityMeasureDocument |
| v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| v3-LOINCObservationActContextAgeDefinitionCode | LOINCObservationActContextAgeDefinitionCode |
| v3-LogicalObservationIdentifierNamesAndCodes | LogicalObservationIdentifierNamesAndCodes |
| v3-LoincDocumentOntologyInternational | LoincDocumentOntologyInternational |
| v3-ObservationActContextAgeGroupType | ObservationActContextAgeGroupType |
| v3-QualityMeasureSectionType | QualityMeasureSectionType |
| v3-immunizationForecastDate | immunizationForecastDate |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.117 | Measured Height (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.118 | Pre-Pregnancy Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.12 | 5 Min Apgar Score (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.120 | Mothers Delivery Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.121 | Previous Other Pregnancy Outcomes (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.122 | Number of Previous Live Births Now Dead (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.123 | Number of Previous Live Births Now Living (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.124 | Obstetric Estimate of Gestation (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.13 | 10 Min Apgar Score (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.132 | Birth Plurality of Delivery (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.133 | First Prenatal Care Visit (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.135 | Number Prenatal Care Visits (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.148 | Number of Previous Cesareans (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.151 | Fetus Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.164 | Number of Fetal Deaths This Delivery (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.179 | Stated Height (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.180 | Conception Date (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.184 | Birthplace Setting (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.185 | Time of Death (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.187 | Number of Preterm Births (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.191 | Institution Referred To (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.20 | Birth Weight (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.59 | Karyotype Result (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.67 | Date of Last Live Birth (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.68 | Number of Live Births (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.69 | Date of Last Menses (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.70 | Date of Last Other Pregnancy Outcome (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.71 | Number of Prior Pregnancies (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.8 | JCIH-EHDI Hearing Screen Left |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.9 | JCIH-EHDI Hearing Screen Right |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.17 | Laboratory Tests (HW) |
| 2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) |
| 2.16.840.1.113883.3.88.12.80.46 | Document Class Value Set |
| 2.16.840.1.113883.3.88.12.80.47 | Document Type Value Set |
| 2.16.840.1.113883.3.88.12.80.62 | Vital Sign Result Value Set |
| 2.16.840.1.114222.4.11.1002 | Lab Test Result Name |
| 2.16.840.1.114222.4.11.1004 | Ordered Test |
| 2.16.840.1.114222.4.11.1071 | Drug Susceptibility Test Result Name |
| 2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name |
| 2.16.840.1.114222.4.11.1107 | Notification Section Header |
| 2.16.840.1.114222.4.11.3000 | PHLIP Questions (Flu) |
| 2.16.840.1.114222.4.11.3016 | Lab Test Order (PHLIP Flu) |
| 2.16.840.1.114222.4.11.3019 | Resulted Lab Test Name (PHLIP Flu) |
| 2.16.840.1.114222.4.11.3043 | Lab Test Result Name (Hepatitis) |
| 2.16.840.1.114222.4.11.3205 | Lab Test Result Name (TB) |
| 2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) |
| 2.16.840.1.114222.4.11.3207 | Lab Test Result Name (Anthrax) |
| 2.16.840.1.114222.4.11.3208 | Lab Test Result Name (Tularemia) |
| 2.16.840.1.114222.4.11.3224 | Blood or body fluid exposure event |
| 2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor |
| 2.16.840.1.114222.4.11.3245 | Radiology Lab Test (Flu) |
| 2.16.840.1.114222.4.11.3300 | Lab Test Procedure (Rubella) |
| 2.16.840.1.114222.4.11.3309 | Lab Test Procedure (Malaria) |
| 2.16.840.1.114222.4.11.3358 | Lab Test Name (NND) |
| 2.16.840.1.114222.4.11.3381 | Observation Identifier (IIS) |
| 2.16.840.1.114222.4.11.3589 | Observation Identifier (Syndromic Surveillance) |
| 2.16.840.1.114222.4.11.4117 | Lab Test Name (Amebiasis) |
| 2.16.840.1.114222.4.11.4118 | Lab Test Name (Anaplasma) |
| 2.16.840.1.114222.4.11.4119 | Lab Test Name (Anthrax) |
| 2.16.840.1.114222.4.11.4120 | Lab Test Name (Arbovirus) |
| 2.16.840.1.114222.4.11.4122 | Lab Test Name (Babesiosis) |
| 2.16.840.1.114222.4.11.4123 | Lab Test Name (Bartonellosis) |
| 2.16.840.1.114222.4.11.4124 | Lab Test Name (Blastomycosis) |
| 2.16.840.1.114222.4.11.4125 | Lab Test Name (Botulism) |
| 2.16.840.1.114222.4.11.4126 | Lab Test Name (Brucellosis) |
| 2.16.840.1.114222.4.11.4127 | Lab Test Name (California serogroup virus) |
| 2.16.840.1.114222.4.11.4128 | Lab Test Name (Campylobacteriosis) |
| 2.16.840.1.114222.4.11.4129 | Lab Test Name (Chagas) |
| 2.16.840.1.114222.4.11.4130 | Lab Test Name (Chancroid) |
| 2.16.840.1.114222.4.11.4131 | Lab Test Name (Chlamydia trachomatis) |
| 2.16.840.1.114222.4.11.4132 | Lab Test Name (Cholera) |
| 2.16.840.1.114222.4.11.4133 | Lab Test Name (Clostridium perfringens) |
| 2.16.840.1.114222.4.11.4134 | Lab Test Name (Coccidioidomycosis) |
| 2.16.840.1.114222.4.11.4135 | Lab Test Name (Colorado Tick Fever) |
| 2.16.840.1.114222.4.11.4137 | Lab Test Name (Cryptococcosis) |
| 2.16.840.1.114222.4.11.4138 | Lab Test Name (Cryptosporidiosis) |
| 2.16.840.1.114222.4.11.4139 | Lab Test Name (Cyclosporiasis) |
| 2.16.840.1.114222.4.11.4140 | Lab Test Name (Cysticercosis) |
| 2.16.840.1.114222.4.11.4141 | Lab Test Name (Dengue) |
| 2.16.840.1.114222.4.11.4142 | Lab Test Name (Diphtheria) |
| 2.16.840.1.114222.4.11.4143 | Lab Test Name (Eastern equine encephalitis virus) |
| 2.16.840.1.114222.4.11.4145 | Lab Test Name (E. coli STEC) |
| 2.16.840.1.114222.4.11.4146 | Lab Test Name (Ehrlichia chaffeensis) |
| 2.16.840.1.114222.4.11.4147 | Lab Test Name (Ehrlichia ewingii) |
| 2.16.840.1.114222.4.11.4148 | Lab Test Name (Ehrlichiosis Anaplasmosis) |
| 2.16.840.1.114222.4.11.4149 | Lab Test Name (Giardiasis) |
| 2.16.840.1.114222.4.11.4150 | Lab Test Name (Glanders) |
| 2.16.840.1.114222.4.11.4151 | Lab Test Name (Gonorrhea) |
| 2.16.840.1.114222.4.11.4152 | Lab Test Name (Granuloma Inguinale) |
| 2.16.840.1.114222.4.11.4153 | Lab Test Name (Haemophilus influenzae) |
| 2.16.840.1.114222.4.11.4155 | Lab Test Name (Hantavirus Pulmonary Syndrome) |
| 2.16.840.1.114222.4.11.4157 | Lab Test Name (Hepatitis A) |
| 2.16.840.1.114222.4.11.4158 | Lab Test Name (Hepatitis B) |
| 2.16.840.1.114222.4.11.4159 | Lab Test Name (Hepatitis C) |
| 2.16.840.1.114222.4.11.4160 | Lab Test Name (Hepatitis D) |
| 2.16.840.1.114222.4.11.4161 | Lab Test Name (Hepatitis E) |
| 2.16.840.1.114222.4.11.4162 | Lab Test Name (Herpes Simplex) |
| 2.16.840.1.114222.4.11.4163 | Lab Test Name (Histoplasmosis) |
| 2.16.840.1.114222.4.11.4164 | Lab Test Name (HIV) |
| 2.16.840.1.114222.4.11.4165 | Lab Test Name (Influenza A virus, H1N1 2009 strain) |
| 2.16.840.1.114222.4.11.4166 | Lab Test Name (Jamestown Canyon virus) |
| 2.16.840.1.114222.4.11.4167 | Lab Test Name (Legionellosis) |
| 2.16.840.1.114222.4.11.4168 | Lab Test Name (Leptospirosis) |
| 2.16.840.1.114222.4.11.4169 | Lab Test Name (Listeriosis) |
| 2.16.840.1.114222.4.11.4170 | Lab Test Name (Lyme disease) |
| 2.16.840.1.114222.4.11.4171 | Lab Test Name (Lymphogranuloma Venereum) |
| 2.16.840.1.114222.4.11.4172 | Lab Test Name (Malaria) |
| 2.16.840.1.114222.4.11.4174 | Lab Test Name (Measles) |
| 2.16.840.1.114222.4.11.4175 | Lab Test Name (Melioidosis) |
| 2.16.840.1.114222.4.11.4176 | Lab Test Name (Meningococcal Disease) |
| 2.16.840.1.114222.4.11.4177 | Lab Test Name (Monkeypox Orthopox) |
| 2.16.840.1.114222.4.11.4178 | Lab Test Name (MRSA) |
| 2.16.840.1.114222.4.11.4179 | Lab Test Name (Mumps) |
| 2.16.840.1.114222.4.11.4181 | Lab Test Name (Nongonococcal Urethritis) |
| 2.16.840.1.114222.4.11.4182 | Lab Test Name (Nontuberculous Mycobacteria) |
| 2.16.840.1.114222.4.11.4183 | Lab Test Name (Norovirus) |
| 2.16.840.1.114222.4.11.4184 | Lab Test Name (Pertussis) |
| 2.16.840.1.114222.4.11.4185 | Lab Test Name (Plague) |
| 2.16.840.1.114222.4.11.4186 | Lab Test Name (Polio) |
| 2.16.840.1.114222.4.11.4187 | Lab Test Name (Powassan virus) |
| 2.16.840.1.114222.4.11.4188 | Lab Test Name (Prion Disease) |
| 2.16.840.1.114222.4.11.4189 | Lab Test Name (Psittacosis) |
| 2.16.840.1.114222.4.11.4190 | Lab Test Name (Q Fever) |
| 2.16.840.1.114222.4.11.4191 | Lab Test Name (Rabies) |
| 2.16.840.1.114222.4.11.4192 | Lab Test Name (Relapsing Fever) |
| 2.16.840.1.114222.4.11.4193 | Lab Test Name (Respiratory Syncytial Virus) |
| 2.16.840.1.114222.4.11.4194 | Lab Test Name (Rickettsial infection, other) |
| 2.16.840.1.114222.4.11.4195 | Lab Test Name (Rift Valley Fever) |
| 2.16.840.1.114222.4.11.4196 | Lab Test Name (Rotavirus) |
| 2.16.840.1.114222.4.11.4197 | Lab Test Name (Rubella) |
| 2.16.840.1.114222.4.11.4198 | Lab Test Name (Salmonellosis) |
| 2.16.840.1.114222.4.11.4199 | Lab Test Name (SARS) |
| 2.16.840.1.114222.4.11.4200 | Lab Test Name (Shigella) |
| 2.16.840.1.114222.4.11.4201 | Lab Test Name (Smallpox) |
| 2.16.840.1.114222.4.11.4202 | Lab Test Name (Spotted fever rickettsiosis) |
| 2.16.840.1.114222.4.11.4203 | Lab Test Name (Staphylococcus aureus) |
| 2.16.840.1.114222.4.11.4204 | Lab Test Name (Staphylococcus aureus enterotoxin B) |
| 2.16.840.1.114222.4.11.4205 | Lab Test Name (Staphylococcus aureus food poisoning) |
| 2.16.840.1.114222.4.11.4206 | Lab Test Name (Staphylococcal TSS) |
| 2.16.840.1.114222.4.11.4207 | Lab Test Name (St. Louis encephalitis virus) |
| 2.16.840.1.114222.4.11.4208 | Lab Test Name (Streptococcus pneumoniae) |
| 2.16.840.1.114222.4.11.4210 | Lab Test Name (Streptococcus, group A) |
| 2.16.840.1.114222.4.11.4211 | Lab Test Name (Streptococcus, group B) |
| 2.16.840.1.114222.4.11.4212 | Lab Test Name (Syphilis) |
| 2.16.840.1.114222.4.11.4213 | Lab Test Name (Tetanus) |
| 2.16.840.1.114222.4.11.4214 | Lab Test Name (Toxoplasmosis) |
| 2.16.840.1.114222.4.11.4215 | Lab Test Name (Trichinellosis) |
| 2.16.840.1.114222.4.11.4216 | Lab Test Name (Tuberculosis) |
| 2.16.840.1.114222.4.11.4217 | Lab Test Name (Tularemia) |
| 2.16.840.1.114222.4.11.4218 | Lab Test Name (Typhoid Fever) |
| 2.16.840.1.114222.4.11.4219 | Lab Test Name (Typhus group rickettsiosis) |
| 2.16.840.1.114222.4.11.4220 | Lab Test Name (Vaccinia) |
| 2.16.840.1.114222.4.11.4221 | Lab Test Name (Vancomycin resistant Enterococcus) |
| 2.16.840.1.114222.4.11.4222 | Lab Test Name (Varicella) |
| 2.16.840.1.114222.4.11.4223 | Lab Test Name (Vesicular Stomatitis) |
| 2.16.840.1.114222.4.11.4224 | Lab Test Name (Non-Cholera Vibrio) |
| 2.16.840.1.114222.4.11.4225 | Lab Test Name (Viral Hemorrhagic Fever) |
| 2.16.840.1.114222.4.11.4228 | Lab Test Name (Western equine encephalitis virus) |
| 2.16.840.1.114222.4.11.4229 | Lab Test Name (West Nile virus) |
| 2.16.840.1.114222.4.11.4230 | Lab Test Name (Yellow Fever) |
| 2.16.840.1.114222.4.11.4231 | Lab Test Name (Yersiniosis) |
| 2.16.840.1.114222.4.11.4239 | Lab Test Name (Diabetes, hemoglobin A1c) |
| 2.16.840.1.114222.4.11.4240 | Lab Test Name (Asbestosis) |
| 2.16.840.1.114222.4.11.4241 | Lab Test Name (Berylliosis) |
| 2.16.840.1.114222.4.11.4242 | Lab Test Name (Ricin poisoning) |
| 2.16.840.1.114222.4.11.4243 | Lab Test Name (Mushroom poisoning) |
| 2.16.840.1.114222.4.11.4244 | Lab Test Name (Carbon monoxide poisoning) |
| 2.16.840.1.114222.4.11.4245 | Lab Test Name (Pesticide poisoning) |
| 2.16.840.1.114222.4.11.4246 | Lab Test Name (Arsenic poisoning) |
| 2.16.840.1.114222.4.11.4247 | Lab Test Name (Cadmium poisoning) |
| 2.16.840.1.114222.4.11.4248 | Lab Test Name (Lead poisoning) |
| 2.16.840.1.114222.4.11.4249 | Lab Test Name (Mercury poisoning) |
| 2.16.840.1.114222.4.11.4250 | Lab Test Name (Acid fast stain) |
| 2.16.840.1.114222.4.11.4251 | Lab Test Name (Bacteria) |
| 2.16.840.1.114222.4.11.4252 | Lab Test Name (Fungus) |
| 2.16.840.1.114222.4.11.4253 | Lab Test Name (Microorganism) |
| 2.16.840.1.114222.4.11.4254 | Lab Test Name (Mycobacteria) |
| 2.16.840.1.114222.4.11.4255 | Lab Test Name (Parasite) |
| 2.16.840.1.114222.4.11.4256 | Lab Test Name (Virus) |
| 2.16.840.1.114222.4.11.4257 | Lab Test Name (Antimicrobial susceptibility tests) |
| 2.16.840.1.114222.4.11.4258 | Lab Test Name (TB Antimicrobial susceptibility test) |
| 2.16.840.1.114222.4.11.5007 | Specimen Related Observations (PHLIP Sal) |
| 2.16.840.1.114222.4.11.5017 | Resulted Lab Test Name PHLIP Salmonella |
| 2.16.840.1.114222.4.11.6013 | Lab Test Type (Hepatitis) |
| 2.16.840.1.114222.4.11.6014 | Lab Test Type Enzymes (Hepatitis) |
| 2.16.840.1.114222.4.11.6053 | Lab Test Name (Reportable Conditions) |
| 2.16.840.1.114222.4.11.6055 | Lab Test Name (HEDIS) |
| 2.16.840.1.114222.4.11.7102 | VPD Lab Test Identifiers |
| 2.16.840.1.114222.4.11.7109 | VPD Lab Order Identifier |
| 2.16.840.1.114222.4.11.7155 | Height (NCHS) |
| 2.16.840.1.114222.4.11.7196 | Non Treponemal Serologic Test (STD) |
| 2.16.840.1.114222.4.11.7197 | Treponemal Serologic Test (STD) |
| 2.16.840.1.114222.4.11.7201 | Lab Tests (STD) |
| 2.16.840.1.114222.4.11.7208 | Newborn Vital Signs (NCHS) |
| 2.16.840.1.114222.4.11.7209 | Maternal Vital Signs (NCHS) |
| 2.16.840.1.114222.4.11.7210 | Apgar Assessments (NCHS) |
| 2.16.840.1.114222.4.11.7243 | Lab Test Name (Ebolavirus) |
| 2.16.840.1.114222.4.11.7246 | Vital Signs (Syndromic Surveillance) |
| 2.16.840.1.114222.4.11.7250 | Observation Identifiers (EVD Triage) |
| 2.16.840.1.114222.4.11.7267 | Death Report Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7268 | Data Elements (NND Gen V2) |
| 2.16.840.1.114222.4.11.7328 | 1 Min Apgar Score (NCHS) |
| 2.16.840.1.114222.4.11.7336 | Lab Test Type (Mumps) |
| 2.16.840.1.114222.4.11.7337 | Lab Test Type (Pertussis) |
| 2.16.840.1.114222.4.11.7339 | Lab Test Name (Chikungunya virus) |
| 2.16.840.1.114222.4.11.7340 | Lab Test Name (Junin Hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7341 | Lab Test Name (Lassa fever) |
| 2.16.840.1.114222.4.11.7342 | Lab Test Name (Marburgvirus) |
| 2.16.840.1.114222.4.11.7352 | No Prenatal Care Visit (NCHS) |
| 2.16.840.1.114222.4.11.7401 | Triage System (NCHS) |
| 2.16.840.1.114222.4.11.7421 | Body Weight (NCHS) |
| 2.16.840.1.114222.4.11.7426 | Estimated Time Of Fetal Death (NCHS) |
| 2.16.840.1.114222.4.11.7430 | Histological Placental Exam Performed (NCHS) |
| 2.16.840.1.114222.4.11.7456 | Lab Test Type (Varicella) |
| 2.16.840.1.114222.4.11.7480 | Lab Test Name (Zika virus) |
| 2.16.840.1.114222.4.11.7515 | Data Elements (NND Hep Core) |
| 2.16.840.1.114222.4.11.7516 | Data Elements (NND Hep A Acute) |
| 2.16.840.1.114222.4.11.7517 | Data Elements (NND Hep B Acute) |
| 2.16.840.1.114222.4.11.7518 | Data Elements (NND Hep B Perinatal) |
| 2.16.840.1.114222.4.11.7519 | Data Elements (NND Hep B Chronic) |
| 2.16.840.1.114222.4.11.7520 | Data Elements (NND Hep C Acute) |
| 2.16.840.1.114222.4.11.7521 | Data Elements (NND Hep C Chronic) |
| 2.16.840.1.114222.4.11.7522 | Data Elements (NND Mumps) |
| 2.16.840.1.114222.4.11.7523 | Data Elements (NND Pertussis) |
| 2.16.840.1.114222.4.11.7524 | Data Elements (NND STD) |
| 2.16.840.1.114222.4.11.7525 | Data Elements (NND CS) |
| 2.16.840.1.114222.4.11.7542 | Lab Test Name (Hantavirus Infection) |
| 2.16.840.1.114222.4.11.7545 | Lab Test Type (Babesiosis) |
| 2.16.840.1.114222.4.11.7546 | NAT Tests (Zika) |
| 2.16.840.1.114222.4.11.7547 | IgM Ab Tests (Zika) |
| 2.16.840.1.114222.4.11.7548 | Neutralizing Ab Tests (Zika) |
| 2.16.840.1.114222.4.11.7549 | Test Type (Syphilis) |
| 2.16.840.1.114222.4.11.7550 | Lab Test Type (STD) |
| 2.16.840.1.114222.4.11.7555 | Susceptibility Test Type (STD) |
| 2.16.840.1.114222.4.11.7583 | Birth Reporting Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7584 | CCOFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7586 | JFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7587 | JLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7588 | PSFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7589 | PSFFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7590 | PSFLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7591 | PSLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7592 | PSMFDI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7594 | PSMLBI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7658 | CREI Observation Type (NCHS) |
| 2.16.840.1.114222.4.11.7661 | Lab Test Type (Measles) |
| 2.16.840.1.114222.4.11.7663 | Data Elements (NND Malaria) |
| 2.16.840.1.114222.4.11.7664 | Data Elements (NND Babesiosis) |
| 2.16.840.1.114222.4.11.7665 | Data Elements (NND Varicella) |
| 2.16.840.1.114222.4.11.7743 | Lab Test Type (TB) |
| 2.16.840.1.114222.4.11.7760 | Susceptibility Test Type (TB) |
| 2.16.840.1.114222.4.11.7780 | Lab Test Name (Crimean-Congo hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7811 | Data Elements (CRS) |
| 2.16.840.1.114222.4.11.7816 | Data Elements (Rubella) |
| 2.16.840.1.114222.4.11.7829 | Series Status (IIS) |
| 2.16.840.1.114222.4.11.7830 | Observation Identifier V2 (IIS) |
| 2.16.840.1.114222.4.11.7835 | Lab Test Type (TBRD) |
| 2.16.840.1.114222.4.11.7844 | Lab Test Type (Lyme) |
| 2.16.840.1.114222.4.11.7853 | MCDI Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7854 | FDDI Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7855 | DR Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7856 | JDI Death Report Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7857 | CREI Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7858 | CCOD Observation Identifier (NCHS) |
| 2.16.840.1.114222.4.11.7893 | Lab Test Name Carbapenem Resistant Enterobacteria |
| 2.16.840.1.114222.4.11.7894 | Lab Test Name (Candida Auris) |
| 2.16.840.1.114222.4.11.7897 | Lab Test Measurement (CO) |
| 2.16.840.1.114222.4.11.7948 | Lab Test Type (COVID-19) |
| 2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) |
| 2.16.840.1.114222.4.11.954 | BioSense Observations |
| IHEXDSclassCode | IHE XDS classCode |
| IHEXDStypeCode | IHE XDS typeCode |
| document-classcodes | Document Class Value Set |
| signal-filerepo-classification | Signal FileRepo Classification |
| KBV_VS_MIO_CMR_Percentile_Body_Measure_Loinc | Perzentilkörpermaß LOINC |
| document-category | DocumentCategory |
| provincial-document-type | Provincial Document Types |
| document-kind-of-document | Document KOD |
| LOINC-ontology-part-types | LOINCOntologyPartTypes |
| documentsubject-matter-domain | Document SMD |
| document-setting | Document Setting |
| document-role | Document Role |
| document-type-of-service | Document TOS |
| KBV_VS_MIO_EMP_Creatinine | Serumkreatinin |
| KBV_VS_MIO_EMP_Glomerular_Filtration_Rate | Glomeruläre Filtrationsrate (GFR) |
| vs-assessment-scales | Assessment Scales |
| vs-assessment | Assessment |
| vs-observations | Observations |
| ncpeh-healthcare-service-speciality-cs | NCPeH HealthcareService Speciality ValueSet |
| mi-document-type | Medical Imaging Document Type |
| provincial-document-types | Provincial Document Types |
| observation-ccdavitalsignresult | Argonaut Vital Sign Codes |
| GenomicTestTypes | Genomic Test Types Value Set |
| loinc-observation-category | LOINC實驗室檢驗檢查報告名稱值集 |
| loinc-observation-code | LOINC實驗室檢驗檢查值集 |
| eHDSILabCode | eHDSI Laboratory Codes |
| eHDSILabStudyType | eHDSI Laboratory Study Types |
| eHDSILaboratoryReportTypes | eHDSI Laboratory Report Types |
| testBakLOINC | Gegenstand der Laboruntersuchung BAK |
| testMykLOINC | Gegenstand der Laboruntersuchung MYK |
| testParLOINC | Gegenstand der Laboruntersuchung PAR |
| testResistenzMolekularLOINC | Gegenstand der Laboruntersuchung Resistenz Molekular |
| testResistenzPhaenotypischLOINC | Gegenstand der Laboruntersuchung Resistenz Phänotypisch |
| testResistenzklassifikationLOINC | Gegenstand der Laboruntersuchung Resistenzklassifikation |
| testResistenzmechanismusLOINC | Gegenstand der Laboruntersuchung Resistenzmechanismus |
| testVirLOINC | Gegenstand der Laboruntersuchung VIR |
| consent-vs | Consent codes from Loinc and Snomed-ct |
| eom-tumor-marker-result-valueset | TumorMarkerTestResultValueSet |
| hobbies | Hobbies |
| vs-meta-accident-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับอุบัติเหตุ |
| vs-meta-cancer-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับมะเร็ง |
| vs-meta-child-development-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับพัฒนาการเด็ก |
| vs-meta-functional-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวข้องกับสมรรถภาพของร่างกาย |
| vs-meta-lab-observations | Metadata: รหัสการตรวจทางห้องปฏิบัติการบางส่วน |
| vs-meta-ncd-observations | Metadata: รหัสการตรวจหรือบริการคัดกรองโรค NCD |
| vs-meta-neonate-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับทารกแรกคลอด |
| vs-meta-physical-observations | Metadata: รหัสการตรวจร่างกาย |
| vs-meta-pregnancy-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับการตั้งครรภ์ |
| vs-meta-social-observations | Metadata: รหัสการตรวจประวัติทางสังคม |
| vs-meta-vital-observations | Metadata: รหัสการตรวจสัญญาณชีพ |
| observation-codes | observation-codes |
| AlertType | AlertType |
| AppearanceScore | AppearanceScore |
| GrimaceScore | GrimaceScore |
| MusleToneScore | MusleToneScore |
| PanelOrBattery | PanelOrBattery |
| PulseScore | PulseScore |
| RespiratoryScore | RespiratoryScore |
| observation-codes | ObservationCodes |
| ndhm-body-measurement | Body Measurement |
| ndhm-general-assessment | General Assessment |
| ndhm-physical-activity | Physical Activity |
| ndhm-vital-signs | Vital Signs |
| ndhm-women-health | Women Health |
| blood-gas-analysis-combined | Blood Gas Analysis Combined |
| sars-cov-2-detection-combined | SARS-CoV-2 Detection Combined |
| lab-tests-gecco | Laboratory Tests GECCO |
| pregnancy-status | Pregnancy Status |
| smoking-status | Smoking Status |
| EAHB_VS_Befund_DurchgefuehrteBehandlungen | Direktverlegung nötig - Status |
| EAHB_VS_Indikation | Indikation |
| condition-severity-uv-ips | Problem Severity - IPS |
| current-smoking-status-uv-ips | Current Smoking Status - IPS |
| edd-method-uv-ips | Pregnancy Expected Delivery Date Method - IPS |
| pregnancies-summary-uv-ips | Pregnancies Summary - IPS |
| pregnancy-status-uv-ips | Pregnancy Status - IPS |
| problem-type-uv-ips | Problem Type - IPS |
| results-laboratory-observations-uv-ips | Results Laboratory Observation - IPS |
| results-pathology-observations-uv-ips | Results Pathology Observation - IPS |
| results-radiology-observations-uv-ips | Results Radiology Observation - IPS |
| results-radiology-txtobs-gps-dicom-loinc-uv-ips | Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS |
| covid-19-obs | COVID-19 related Observation codes |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20150401000000 | AlertTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20150401000000 | TestNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20171231000000 | AdemhalingScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20171231000000 | AlertTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.53.11.1--20200618120422 | GlucoseMeetmomentenLOINCCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.2--20171231000000 | HartslagScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.4--20171231000000 | HuidskleurScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.5--20171231000000 | OnderzoekCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.5--20171231000000 | ReflexenScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.3--20171231000000 | SpierspanningScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20171231000000 | TestCodeCodelijst |
| dataelement-sdcobjectclass | DataElement SDC Object Class |
| dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| il-hdp-document-types | ILHDP Document Reference Types |
| IVR-VS-patient | IVR valueset patient |
| mni-obs-laboratory | MedNet Interface (MNI) - Laboratory Observation ValueSet |
| BloodGlucoseMarkVS | BloodGlucoseMarkVS |
| dataelement-sdccode | DataElement SDC Concept |
| lab-orderCodes-it-lab | Codice Richiesta esame di Laboratorio [LOINC] |
| risultato-osservazione | Tipo Osservazione |
| sezione-referto-laboratorio | Sezioni Composition Lab Report |
| KBV_VS_MIO_TELE_Clinical_Course | Verlauf |
| KBV_VS_MIO_TELE_Procedure_And_Recommendations | Weiteres Procedere und Empfehlung |
| chronic-condition-set | ChronicConditions |
| fever-class | Feverclass |
| housing-situation | Housingsituation |
| occupation-class | Occupationclass |
| LL4129-4 | Pregnant|Not pregnant|Unknown |
| shared-location-class | Sharedlocationclass |
| yesno | Yesno |
| yesnodontknow | Yesnodontknow |
| vs-laboratory-observations | Laboratory Observations |
| laboratoryTestSARSCoV2 | SARS-CoV-2-Labortest |
| laboratoryTestWBGP | Labortest für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit |
| Laborbereich | MII VS Labor Laborbereich |
| ValueSetOrderCodes | MII VS Labor Order Codes |
| 1.2.91.13925.17760.19613338 | Immunoglobulin G Testing Grouping |
| 1.2.91.13925.17760.26878039 | Specific IgE Testing |
| 1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes |
| 1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1 | Selected urine drug screens for opioids indicating testing is complete |
| 1.3.6.1.4.1.6997.4.1.2.234.999.2 | Selected urine screening for patients receiving opioid therapy |
| 1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272 | Specific IgE Testing for Allergies |
| 1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273 | Immunoglobulin G Testing |
| 1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274 | Total IgE Testing |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594 | Complete Blood Count (with Diff) |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665 | Creatinine |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698 | Clostridium Difficile Test |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647 | Body Temperature |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651 | Leukocyte count |
| 2.16.840.1.113762.1.4.1029.183 | Neonatal Moderate Neurological Complications with LOS Procedures |
| 2.16.840.1.113762.1.4.1029.184 | Neonatal Moderate Neurological Complications with LOS Procedures |
| 2.16.840.1.113762.1.4.1029.194 | Birth Weight |
| 2.16.840.1.113762.1.4.1032.21 | ALT |
| 2.16.840.1.113762.1.4.1032.28 | Urine drug screen for pain management |
| 2.16.840.1.113762.1.4.1032.298 | Cervical Cytology Test |
| 2.16.840.1.113762.1.4.1032.299 | HPV 16 Tests |
| 2.16.840.1.113762.1.4.1032.300 | HPV 18 Tests |
| 2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk |
| 2.16.840.1.113762.1.4.1032.322 | Test 123 |
| 2.16.840.1.113762.1.4.1032.55 | Risk assessments relevant to pain management |
| 2.16.840.1.113762.1.4.1032.87 | Fasting Plasma Glucose |
| 2.16.840.1.113762.1.4.1032.88 | Waist Circumference |
| 2.16.840.1.113762.1.4.1032.94 | Glucose Tolerance Test Results |
| 2.16.840.1.113762.1.4.1045.114 | Hematocrit Lab Test |
| 2.16.840.1.113762.1.4.1045.117 | Potassium Lab Test |
| 2.16.840.1.113762.1.4.1045.119 | Sodium Lab Test |
| 2.16.840.1.113762.1.4.1045.127 | Platelet Count Lab Test |
| 2.16.840.1.113762.1.4.1045.129 | White Blood Cells Count Lab Test |
| 2.16.840.1.113762.1.4.1045.130 | Respiratory Rate |
| 2.16.840.1.113762.1.4.1045.134 | Glucose Lab Test |
| 2.16.840.1.113762.1.4.1045.139 | Bicarbonate Lab Test |
| 2.16.840.1.113762.1.4.1045.151 | Oxygen Saturation by Pulse Oximetry |
| 2.16.840.1.113762.1.4.1045.152 | Body Temperature |
| 2.16.840.1.113762.1.4.1045.159 | Body Weight |
| 2.16.840.1.113762.1.4.1045.163 | Systolic Blood Pressure |
| 2.16.840.1.113762.1.4.1045.26 | Estimated Gestational Age at Delivery |
| 2.16.840.1.113762.1.4.1046.35 | Healthcare Agent or Proxy Choices |
| 2.16.840.1.113762.1.4.1047.561 | Intraocular pressure |
| 2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings |
| 2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests |
| 2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load |
| 2.16.840.1.113762.1.4.1078.1041 | Hemoglobin |
| 2.16.840.1.113762.1.4.1078.1042 | Hematocrit |
| 2.16.840.1.113762.1.4.1078.1047 | Ferritin |
| 2.16.840.1.113762.1.4.1078.197 | Blood (Serum and Plasma) Potassium |
| 2.16.840.1.113762.1.4.1078.202 | Serum Creatinine |
| 2.16.840.1.113762.1.4.1078.34 | Blood pressure panel |
| 2.16.840.1.113762.1.4.1078.35 | Systolic Blood Pressure |
| 2.16.840.1.113762.1.4.1078.397 | eGFR |
| 2.16.840.1.113762.1.4.1078.415 | LDL Cholesterol |
| 2.16.840.1.113762.1.4.1078.43 | Urinalysis |
| 2.16.840.1.113762.1.4.1078.442 | Blood Glucose |
| 2.16.840.1.113762.1.4.1078.517 | Hemoglobin A1c |
| 2.16.840.1.113762.1.4.1078.551 | Heart Rate |
| 2.16.840.1.113762.1.4.1078.599 | PIM_Vitamin B12 Level_LOINC_CPT |
| 2.16.840.1.113762.1.4.1078.600 | PIM_Vitamin B12 Level_LOINC |
| 2.16.840.1.113762.1.4.1078.629 | PIM_Refill_Request_Antilipemics_LFTs |
| 2.16.840.1.113762.1.4.1078.700 | PIM_DEXA_Scan |
| 2.16.840.1.113762.1.4.1078.701 | PIM_DEXA_Scan_CPT_LOINC |
| 2.16.840.1.113762.1.4.1078.746 | Influenza (Tests for influenza A or B virus Antigen) |
| 2.16.840.1.113762.1.4.1078.756 | Respiratory Rate LOINC |
| 2.16.840.1.113762.1.4.1078.757 | Respiratory Rate |
| 2.16.840.1.113762.1.4.1078.775 | Arterial oxygen saturation LOINC |
| 2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation |
| 2.16.840.1.113762.1.4.1078.863 | PIM_Thyroid_Stimulating_Hormone_(TSH) |
| 2.16.840.1.113762.1.4.1078.864 | PIM_Triiodothyronine_(T3) |
| 2.16.840.1.113762.1.4.1078.865 | PIM_Thyroxine_(T4) |
| 2.16.840.1.113762.1.4.1078.866 | PIM_Magnesium_LOINC |
| 2.16.840.1.113762.1.4.1078.867 | PIM_BMP_CMP_LOINC |
| 2.16.840.1.113762.1.4.1078.868 | PIM_URIC_ACID_LOINC |
| 2.16.840.1.113762.1.4.1078.952 | OIA_Creatinine_Levels_LOINC |
| 2.16.840.1.113762.1.4.1078.969 | OIA_Microalbumin |
| 2.16.840.1.113762.1.4.1078.970 | OIA_LDL_Cholesterol |
| 2.16.840.1.113762.1.4.1078.98 | BMI LOINC |
| 2.16.840.1.113762.1.4.1095.21 | Nutrition Assessment |
| 2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment |
| 2.16.840.1.113762.1.4.1095.34 | Malnutrition Screening Finding of Not At Risk Result |
| 2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished |
| 2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished |
| 2.16.840.1.113762.1.4.1095.74 | Nutrition Anthropometric Measure Panel LOINC |
| 2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping |
| 2.16.840.1.113762.1.4.1095.78 | Food and Nutrition Related History LOINC |
| 2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping |
| 2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result |
| 2.16.840.1.113762.1.4.1095.92 | Malnutrition Risk Screening |
| 2.16.840.1.113762.1.4.1095.94 | Malnutrition Screening Finding of At Risk Result |
| 2.16.840.1.113762.1.4.1095.95 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| 2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| 2.16.840.1.113762.1.4.1095.97 | Nutrition Assessment Status Finding of Severely Malnourished |
| 2.16.840.1.113762.1.4.1095.98 | Nutrition Assessment Status Finding of Moderately Malnourished |
| 2.16.840.1.113762.1.4.1096.225 | Laboratory results that are used in medication management |
| 2.16.840.1.113762.1.4.1096.240 | Medication Lists |
| 2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type |
| 2.16.840.1.113762.1.4.1099.28 | Problem Type (LOINC) |
| 2.16.840.1.113762.1.4.1099.36 | Arthritis Feedback Types (LOINC) |
| 2.16.840.1.113762.1.4.1099.4 | DIRSectionTypeCodes LOINC |
| 2.16.840.1.113762.1.4.1099.49 | Disability Status Assessment |
| 2.16.840.1.113762.1.4.1099.55 | At Home In Vitro Patient Questions |
| 2.16.840.1.113762.1.4.1099.57 | Advance Directives Content Type |
| 2.16.840.1.113762.1.4.1111.163 | Emergency Department Evaluation |
| 2.16.840.1.113762.1.4.1115.10 | Care Experience Preferences at End of Life LOINC |
| 2.16.840.1.113762.1.4.1115.11 | Care Experience Preferences Grouping |
| 2.16.840.1.113762.1.4.1115.13 | Healthcare Agent Powers or Limitations Indicator |
| 2.16.840.1.113762.1.4.1115.14 | ADIClauseTypeVS |
| 2.16.840.1.113762.1.4.1115.15 | Upon Death Preferences |
| 2.16.840.1.113762.1.4.1115.17 | Preconditions for Treatment Preferences |
| 2.16.840.1.113762.1.4.1115.18 | Treatment Intervention Preferences at End of Life Ordinal LOINC |
| 2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping |
| 2.16.840.1.113762.1.4.1115.21 | Witness Categories |
| 2.16.840.1.113762.1.4.1115.22 | Advance Directive Document Types |
| 2.16.840.1.113762.1.4.1115.23 | AD Conditions and Prognosis Scenarios |
| 2.16.840.1.113762.1.4.1115.26 | Healthcare Agent or Advisor Indicator |
| 2.16.840.1.113762.1.4.1115.27 | Initial Treatment portable medical order options |
| 2.16.840.1.113762.1.4.1115.28 | Cardiopulmonary Resuscitation Order Options |
| 2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.35 | Medically Assisted Nutrition Order Options |
| 2.16.840.1.113762.1.4.1115.36 | Medically Assisted Nutrition Portable Medical Order Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.37 | Healthcare Agent Powers |
| 2.16.840.1.113762.1.4.1115.38 | Personal Health Goal Options LOINC |
| 2.16.840.1.113762.1.4.1115.39 | Personal Health Goal Options Grouping |
| 2.16.840.1.113762.1.4.1115.40 | Portable Medical Order Document Types |
| 2.16.840.1.113762.1.4.1115.41 | Advance Healthcare Directive Document Types Grouper |
| 2.16.840.1.113762.1.4.1115.6 | Personal Health Goals LOINC |
| 2.16.840.1.113762.1.4.1115.7 | Health Goals Grouping |
| 2.16.840.1.113762.1.4.1115.8 | Treatment Intervention Preferences at End of Life LOINC |
| 2.16.840.1.113762.1.4.1115.9 | Treatment Intervention Preferences Grouping |
| 2.16.840.1.113762.1.4.1116.161 | ECOG Performance Status |
| 2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status |
| 2.16.840.1.113762.1.4.1125.7 | PROMIS Depression Assessment |
| 2.16.840.1.113762.1.4.1130.15 | Body Temperature |
| 2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection |
| 2.16.840.1.113762.1.4.1142.14 | C2S Cannabis Use Disorders |
| 2.16.840.1.113762.1.4.1142.21 | C2S Hallucinogens |
| 2.16.840.1.113762.1.4.1142.25 | C2S HIV/AIDS Information Sensitivity |
| 2.16.840.1.113762.1.4.1142.34 | C2S Mental Health Disorders |
| 2.16.840.1.113762.1.4.1142.40 | C2S Opioids |
| 2.16.840.1.113762.1.4.1142.5 | C2S Alcohol Use Disorders |
| 2.16.840.1.113762.1.4.1142.56 | C2S Substance Use Information Sensitivity |
| 2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories |
| 2.16.840.1.113762.1.4.1142.9 | C2S Amphetamine Use Disorders |
| 2.16.840.1.113762.1.4.1146.10 | Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1002 | Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1017 | S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1040 | Organisms (Tests by Unspecified Method) |
| 2.16.840.1.113762.1.4.1146.1041 | Organisms (Tests by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.1044 | Candida auris Infection (Tests for Candida auris by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1045 | Candida auris Infection (Tests for Candida auris Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1076 | Opioid Overdose and Poisoning (Tests for Opioids [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.1106 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site) |
| 2.16.840.1.113762.1.4.1146.1130 | Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1131 | Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay |
| 2.16.840.1.113762.1.4.1146.1138 | Staphylococcus Aureus (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1139 | VISA/VRSA (Tests for Vancomycin Resistance Gene) |
| 2.16.840.1.113762.1.4.1146.1142 | COVID_19 (Tests for SARS_CoV_2 Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1148 | Tests for Vancomycin Susceptibility [Ord] |
| 2.16.840.1.113762.1.4.1146.1149 | Proteinuria (Tests for Total Protein in 24H Urine) |
| 2.16.840.1.113762.1.4.1146.1150 | Thrombocytopenia (Tests for Platelets [#/volume] in Blood) |
| 2.16.840.1.113762.1.4.1146.1158 | COVID_19 (Tests for SARS_CoV_2 Antigen) |
| 2.16.840.1.113762.1.4.1146.1169 | Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1180 | Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.1186 | Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1188 | Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1189 | California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1196 | Anthrax (Tests for Bacillus cereus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1215 | Tests for carbapenemase production |
| 2.16.840.1.113762.1.4.1146.1216 | Tests for carbapenemase resistance mechanism |
| 2.16.840.1.113762.1.4.1146.1217 | Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem] |
| 2.16.840.1.113762.1.4.1146.1218 | Tests for carbapenem susceptibility [Ertapenem] |
| 2.16.840.1.113762.1.4.1146.1219 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.1220 | NU_Tests for Enterobacteriaceae species by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.1249 | Blastomycosis (Tests for Blastomyces species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1250 | Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1251 | Blastomycosis (Tests for Blastomyces species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1252 | Blastomycosis (Tests for Blastomyces species Antibody) |
| 2.16.840.1.113762.1.4.1146.1253 | Blastomycosis (Tests for Blastomyces species Antigen) |
| 2.16.840.1.113762.1.4.1146.1281 | Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody) |
| 2.16.840.1.113762.1.4.1146.1304 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1305 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen) |
| 2.16.840.1.113762.1.4.1146.1306 | Body Temperature (Vital Sign) |
| 2.16.840.1.113762.1.4.1146.1307 | Respiratory Rate (Vital Sign) |
| 2.16.840.1.113762.1.4.1146.1312 | RSV (Tests for RSV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1330 | Tobacco Smoking Status [Current] (Social History) (LOINC) |
| 2.16.840.1.113762.1.4.1146.1340 | Prion Disease (Tests for 14_3_3 Protein) |
| 2.16.840.1.113762.1.4.1146.1341 | Prion Disease (Tests for Abnormal Prion Protein) |
| 2.16.840.1.113762.1.4.1146.1359 | Hepatitis E (Tests for hepatitis E virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1360 | Hepatitis E (Tests for hepatitis E virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1364 | Organisms (Tests by Microscopic Observation by Gram Stain) |
| 2.16.840.1.113762.1.4.1146.1378 | Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen |
| 2.16.840.1.113762.1.4.1146.1400 | Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.1409 | COVID_19 (Tests for SARS_CoV_2 Genomic Sequence) |
| 2.16.840.1.113762.1.4.1146.1420 | Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.1452 | MRSA (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1453 | MRSA (Tests for Methicillin Resistance Gene) |
| 2.16.840.1.113762.1.4.1146.1454 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1458 | Tests for Cefoxitin Susceptibility [OrdQn] |
| 2.16.840.1.113762.1.4.1146.1459 | Organisms (Tests in Blood by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.1460 | Bacteria (Tests in Blood by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1461 | Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.1462 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood) |
| 2.16.840.1.113762.1.4.1146.1465 | VRE (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1466 | Enterococcus species (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1476 | Amebiasis (Tests for Entamoeba histolytica Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1482 | Norovirus (Tests for Norovirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1491 | C. diff infection (Tests for C diff Toxin Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1492 | C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool) |
| 2.16.840.1.113762.1.4.1146.1509 | Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.1520 | Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1523 | Cryptococcosis (Tests for Cryptococcus species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1524 | Cryptococcosis (Tests for Cryptococcus species Antigen) |
| 2.16.840.1.113762.1.4.1146.1528 | Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.1565 | Viruses [Causing Meningitis] (Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1566 | Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.1567 | Bacteria [Causing Meningitis] (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1577 | Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1578 | Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1641 | Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.1642 | Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1643 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence) |
| 2.16.840.1.113762.1.4.1146.1654 | Chagas Disease (Tests for Trypanosoma cruzi Antibody) |
| 2.16.840.1.113762.1.4.1146.1676 | Tests for Acinetobacter baumannii Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1677 | Tests for Pseudomonas aeruginosa by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.1678 | Tests for Pseudomonas aeruginosa Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1723 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1725 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1726 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1735 | Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1746 | Rotavirus Disease (Tests for Rotavirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1753 | Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1769 | Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody) |
| 2.16.840.1.113762.1.4.1146.1781 | Herpes (Tests for Herpes simplex virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1788 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence) |
| 2.16.840.1.113762.1.4.1146.1803 | Bacteria (Tests in Sputum Specimen by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1819 | Louseborne relapsing fever (Tests for Borrelia species) |
| 2.16.840.1.113762.1.4.1146.1820 | Louseborne relapsing fever (Tests for Borrelia species in Blood) |
| 2.16.840.1.113762.1.4.1146.1846 | Leishmaniasis (Tests for Leishmania species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1847 | Leishmaniasis (Tests for Leishmania species Antibody) |
| 2.16.840.1.113762.1.4.1146.1848 | Leishmania species (Tests by Microscopic Observation in Tissue) |
| 2.16.840.1.113762.1.4.1146.1875 | Cysticercosis (Tests for Taenia solium Antibody) |
| 2.16.840.1.113762.1.4.1146.1880 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1881 | NU_Tests for Enterobacteriaceae species Nucleic Acid |
| 2.16.840.1.113762.1.4.1146.1897 | Toxoplasmosis (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.1898 | Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1901 | Toxoplasmosis (Tests for Toxoplasma gondii Antibody) |
| 2.16.840.1.113762.1.4.1146.1908 | Organisms (Tests by Electron Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.1919 | Fungi [Causing Meningitis] (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.1933 | C reactive protein (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.1934 | Lymphocytes [Concentration] (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.1937 | Strongyloidiasis (Tests for Strongyloides Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1938 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.1939 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood) |
| 2.16.840.1.113762.1.4.1146.1940 | Organisms (Tests by Microscopic Observation in Stool) |
| 2.16.840.1.113762.1.4.1146.1944 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1945 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1946 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1952 | La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1953 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1954 | La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1955 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1956 | La Crosse Virus Diseases (Tests for La Crosse Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1957 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1958 | Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.1970 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.1971 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1972 | Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1976 | Baylisascariasis (Tests for Baylisascaris species Antibody) |
| 2.16.840.1.113762.1.4.1146.1983 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.1984 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.1985 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody) |
| 2.16.840.1.113762.1.4.1146.2002 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2003 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood) |
| 2.16.840.1.113762.1.4.1146.2004 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody) |
| 2.16.840.1.113762.1.4.1146.2005 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum) |
| 2.16.840.1.113762.1.4.1146.2009 | Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2010 | Eosinophils [Concentration] (Tests in CSF by Any Method) |
| 2.16.840.1.113762.1.4.1146.2011 | Eosinophils [Percentage] (Tests in CSF by Any Method) |
| 2.16.840.1.113762.1.4.1146.2012 | Mpox (Tests for mpox virus by Genomic Sequencing) |
| 2.16.840.1.113762.1.4.1146.2013 | Mpox (Test Panels for mpox virus by Genomic Sequencing) |
| 2.16.840.1.113762.1.4.1146.2039 | Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2040 | Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2041 | Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2042 | Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2043 | Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2044 | Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2045 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2046 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2047 | Bartonellosis (Tests for Bartonella spp. Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2048 | Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2049 | Bartonella spp. (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2050 | Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2051 | Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method) |
| 2.16.840.1.113762.1.4.1146.2058 | Echinococcosis (Tests for Echinococcus species Antibody) |
| 2.16.840.1.113762.1.4.1146.2059 | Echinococcus species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2067 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen) |
| 2.16.840.1.113762.1.4.1146.2085 | Leukocytes [Concentration] (Tests in Blood by Any Method) |
| 2.16.840.1.113762.1.4.1146.2095 | Gonorrhea (Tests for Neisseria gonorrhoeae Antigen) |
| 2.16.840.1.113762.1.4.1146.2103 | Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum) |
| 2.16.840.1.113762.1.4.1146.2109 | Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2128 | Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly) |
| 2.16.840.1.113762.1.4.1146.2139 | Prion Disease (Tests for Abnormal PRNP Gene Variant) |
| 2.16.840.1.113762.1.4.1146.2149 | NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2152 | Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2156 | Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method) |
| 2.16.840.1.113762.1.4.1146.2157 | Mpox (Combination Tests that include mpox virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2158 | Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2159 | Mpox (Test Panels for mpox virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.216 | Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody]) |
| 2.16.840.1.113762.1.4.1146.2160 | Orthopox (Test Panels for orthopoxvirus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2161 | COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2166 | Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody) |
| 2.16.840.1.113762.1.4.1146.2167 | Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2168 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2169 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2170 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2171 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2172 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2173 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2174 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2175 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2176 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2177 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2178 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2179 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2180 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2181 | Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2183 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2187 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2188 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2189 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2190 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2192 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2193 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2194 | Organisms (Combination Tests by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2195 | Organisms (Combination Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2199 | NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.2200 | Organisms (Tests by Animal Inoculation Method) |
| 2.16.840.1.113762.1.4.1146.2206 | Creatinine (Tests in Serum by Any Method) |
| 2.16.840.1.113762.1.4.1146.2207 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen) |
| 2.16.840.1.113762.1.4.1146.2208 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood) |
| 2.16.840.1.113762.1.4.1146.2210 | Histopathology or Cytopathology Tests by Microscopic Observation |
| 2.16.840.1.113762.1.4.1146.2211 | Ehrlichiosis (Tests for Ehrlichia species IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.2213 | Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2222 | Organisms (Tests in Amniotic Fluid by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2223 | Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2224 | Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2225 | Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2226 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT) |
| 2.16.840.1.113762.1.4.1146.2227 | Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood) |
| 2.16.840.1.113762.1.4.1146.2228 | Congenital Cytomegalovirus (Tests for CMV Antigen) |
| 2.16.840.1.113762.1.4.1146.2229 | Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2230 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT) |
| 2.16.840.1.113762.1.4.1146.2235 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2236 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain) |
| 2.16.840.1.113762.1.4.1146.2237 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody) |
| 2.16.840.1.113762.1.4.1146.2238 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood) |
| 2.16.840.1.113762.1.4.1146.2239 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.2240 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid) |
| 2.16.840.1.113762.1.4.1146.2243 | Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF) |
| 2.16.840.1.113762.1.4.1146.2244 | Candida species (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2245 | Organisms (Tests in Extrapulmonary Specimen by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2246 | Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen) |
| 2.16.840.1.113762.1.4.1146.2248 | Plasmodium species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2249 | Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF) |
| 2.16.840.1.113762.1.4.1146.2251 | Organisms (Tests in Sputum Specimen by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2252 | Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2253 | Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] ) |
| 2.16.840.1.113762.1.4.1146.2254 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2257 | Organisms (Tests in Stool by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2293 | Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.2294 | NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method) |
| 2.16.840.1.113762.1.4.1146.2299 | Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2300 | Babesia species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2301 | Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2302 | Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2303 | Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2304 | Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) |
| 2.16.840.1.113762.1.4.1146.2306 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2343 | Giardiasis (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2344 | Diphtheria (Tests for Diphtheria Toxin Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2345 | Lead in Blood (Tests for Lead in Venous Blood) |
| 2.16.840.1.113762.1.4.1146.2346 | Lead in Blood (Tests for Lead in Capillary Blood) |
| 2.16.840.1.113762.1.4.1146.2347 | Opioid Overdose and Poisoning (Test Panels for Opioids) |
| 2.16.840.1.113762.1.4.1146.2348 | Rubella (Test Panels for rubella virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.2351 | Shigellosis (Combination Tests that include Shigella species by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2352 | Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain) |
| 2.16.840.1.113762.1.4.1146.2353 | Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain) |
| 2.16.840.1.113762.1.4.1146.2354 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain) |
| 2.16.840.1.113762.1.4.1146.2355 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin) |
| 2.16.840.1.113762.1.4.1146.2357 | Organisms (Tests by Microscopic Observation in Skin) |
| 2.16.840.1.113762.1.4.1146.2359 | Organisms (Tests by Microscopic Observation in Unspecified Tissue) |
| 2.16.840.1.113762.1.4.1146.2360 | S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2361 | S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2379 | Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2380 | Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2382 | Chagas Disease (Tests for Trypanosoma cruzi in specimen from donor) |
| 2.16.840.1.113762.1.4.1146.2388 | Hansen’s Disease (Tests for M. leprae or M. lepromatosis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.239 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.240 | Chlamydia trachomatis Infection (Tests for Chlamydia trachomatis Antigen) |
| 2.16.840.1.113762.1.4.1146.2403 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus Antibody) |
| 2.16.840.1.113762.1.4.1146.2404 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.2405 | Hepatitis D Virus Infection (Test for hepatitis D virus Antigen) |
| 2.16.840.1.113762.1.4.1146.2406 | Hepatitis B Virus Infection (Combination Tests that include hepatitis B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2409 | Babesiosis (Tests for B. microti IgG or Total Antibody [Titer]) |
| 2.16.840.1.113762.1.4.1146.2410 | Babesiosis (Tests for B. divergens IgG or Total Antibody [Titer]) |
| 2.16.840.1.113762.1.4.1146.2411 | Babesiosis (Tests for B. duncani IgG or Total Antibody [Titer]) |
| 2.16.840.1.113762.1.4.1146.2412 | Babesiosis (Tests for Babesia species IgG or Total Antibody) |
| 2.16.840.1.113762.1.4.1146.2413 | Brucellosis (Tests for Brucella species IgG Antibody by ELISA) |
| 2.16.840.1.113762.1.4.1146.2426 | Leptospira species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2427 | Leptospirosis (Tests for Leptospira Antibody by Agglutination) |
| 2.16.840.1.113762.1.4.1146.2428 | Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence) |
| 2.16.840.1.113762.1.4.1146.244 | Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2440 | Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody) |
| 2.16.840.1.113762.1.4.1146.2441 | Anthrax (Tests for Bacillus species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2448 | Influenza (Tests for unspecified influenza virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2449 | Influenza (Tests for influenza B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2450 | Influenza (Tests for unspecified influenza virus Antigen) |
| 2.16.840.1.113762.1.4.1146.2451 | Influenza (Tests for influenza B virus Antigen) |
| 2.16.840.1.113762.1.4.1146.2454 | Influenza (Tests for unspecified influenza virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2455 | Influenza (Tests for influenza B virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2456 | Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody) |
| 2.16.840.1.113762.1.4.1146.2457 | Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2458 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2459 | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood) |
| 2.16.840.1.113762.1.4.1146.2460 | Borrelia species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2461 | Borrelia species (Tests by Microscopic Observation in Blood) |
| 2.16.840.1.113762.1.4.1146.2462 | Spirochetes (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.2465 | CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2466 | CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2467 | CRE (Tests for Enterobacterales species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2468 | CRE (Combination Tests that include Enterobacterales by Culture and Identification) |
| 2.16.840.1.113762.1.4.1146.2469 | Tests for Carbapenem Susceptibility [Meropenem and Doripenem] |
| 2.16.840.1.113762.1.4.1146.2505 | Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly) |
| 2.16.840.1.113762.1.4.1146.2508 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood) |
| 2.16.840.1.113762.1.4.1146.2509 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood) |
| 2.16.840.1.113762.1.4.1146.2510 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood) |
| 2.16.840.1.113762.1.4.1146.2511 | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2512 | Galactosemia (Tests for Galactokinase (GALK) [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2513 | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.2514 | Galactosemia (Tests for GALT gene allele 1) |
| 2.16.840.1.113762.1.4.1146.2515 | Galactosemia (Tests for GALT gene allele 2) |
| 2.16.840.1.113762.1.4.1146.2522 | Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly) |
| 2.16.840.1.113762.1.4.1146.2523 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.2524 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2525 | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen) |
| 2.16.840.1.113762.1.4.1146.2526 | Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2530 | Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2532 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.2533 | Congenital Cytomegalovirus (Tests for CMV Antibody) |
| 2.16.840.1.113762.1.4.1146.268 | Mumps (Tests for mumps virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.282 | Varicella (Tests for Varicella zoster virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.283 | Varicella (Tests for Varicella zoster virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.297 | Measles (Tests for measles virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.299 | Measles (Tests for measles virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.301 | Shigellosis (Tests for Shigella species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.305 | Organisms (Tests by Microscopic Observation in Specimen from Normally Sterile Site by Gram Stain) |
| 2.16.840.1.113762.1.4.1146.307 | Leptospirosis (Tests for Leptospira IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.308 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.310 | Bacteria (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.311 | Viruses (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.316 | Rubella (Tests for rubella virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.317 | Shigellosis (Tests for Shigella species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.319 | Fungi (Tests by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.335 | Influenza (Tests for influenza A virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.336 | Influenza (Tests for influenza A or B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.342 | Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.343 | Campylobacteriosis (Tests for Campylobacter species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.344 | Campylobacteriosis (Tests for Campylobacter species Antigen) |
| 2.16.840.1.113762.1.4.1146.349 | Hepatitis A (Tests for hepatitis A virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.372 | Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.376 | Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.379 | Giardiasis (Tests for Giardia species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.384 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.388 | Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.390 | Trichinellosis (Tests for Trichinella species Antibody) |
| 2.16.840.1.113762.1.4.1146.398 | Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.399 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen) |
| 2.16.840.1.113762.1.4.1146.400 | Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.401 | Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen) |
| 2.16.840.1.113762.1.4.1146.403 | Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.407 | Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody) |
| 2.16.840.1.113762.1.4.1146.427 | STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.436 | Coccidioidomycosis (Tests for Coccidioides species IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.437 | Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.438 | Coccidioidomycosis (Tests for Coccidioides species Antigen) |
| 2.16.840.1.113762.1.4.1146.445 | Legionellosis (Tests for Legionella species Antigen) |
| 2.16.840.1.113762.1.4.1146.446 | Legionellosis (Tests for Legionella species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.464 | Malaria (Tests for Plasmodium species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.468 | Leptospirosis (Tests for Leptospira Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.471 | Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination) |
| 2.16.840.1.113762.1.4.1146.472 | Leptospirosis (Tests for Leptospira Antibody) |
| 2.16.840.1.113762.1.4.1146.476 | Babesia species (Tests by Microscopic Observation in Blood) |
| 2.16.840.1.113762.1.4.1146.478 | Anthrax (Tests for Bacillus anthracis by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.479 | Anthrax (Tests for Bacillus anthracis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.480 | Anthrax (Tests for Bacillus anthracis Antigen) |
| 2.16.840.1.113762.1.4.1146.481 | Anthrax (Tests for Bacillus anthracis Antibody) |
| 2.16.840.1.113762.1.4.1146.496 | Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen]) |
| 2.16.840.1.113762.1.4.1146.500 | Q Fever (Tests for Coxiella burnetii Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.512 | Brucellosis (Tests for Brucella species Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.515 | Brucellosis (Tests for Brucella species Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.519 | Dengue Virus Infection (Tests for dengue virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.523 | Dengue Virus Infection (Tests for dengue virus Antigen) |
| 2.16.840.1.113762.1.4.1146.524 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.525 | Dengue Virus Infection (Tests for dengue virus IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.527 | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.530 | Borrelia species (Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.531 | Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot) |
| 2.16.840.1.113762.1.4.1146.532 | Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay) |
| 2.16.840.1.113762.1.4.1146.548 | St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.550 | Syphilis (Tests for Treponema pallidum Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.553 | Anaplasma species (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.555 | Yellow Fever (Tests for yellow fever virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.557 | Yellow Fever (Tests for yellow fever virus Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.560 | West Nile Virus Infection (Tests for West Nile virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.569 | Plague (Tests for Yersinia pestis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.575 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.576 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen) |
| 2.16.840.1.113762.1.4.1146.577 | Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody) |
| 2.16.840.1.113762.1.4.1146.578 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative]) |
| 2.16.840.1.113762.1.4.1146.579 | Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.58 | Pertussis (Tests for Bordetella pertussis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.581 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.584 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.595 | Tularemia (Tests for Francisella tularensis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.598 | Tularemia (Tests for Francisella tularensis Antibody) |
| 2.16.840.1.113762.1.4.1146.605 | Organisms (Tests by Microscopic Observation by Acid Fast Stain) |
| 2.16.840.1.113762.1.4.1146.614 | Pertussis (Tests for Bordetella pertussis Toxin Antibody) |
| 2.16.840.1.113762.1.4.1146.645 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.652 | Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.70 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.705 | Syphilis (Tests for Treponemal or Non Treponemal Antibody) |
| 2.16.840.1.113762.1.4.1146.71 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.728 | HIV Infection (Tests for HIV Nucleic Acid [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.730 | HIV Infection (Tests for HIV Antibody) |
| 2.16.840.1.113762.1.4.1146.744 | Coccidioidomycosis (Tests for Coccidioides species IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.746 | Treponema pallidum (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.762 | Mumps (Test Panels for mumps virus IgM IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.764 | Mumps (Tests for mumps virus IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.770 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site) |
| 2.16.840.1.113762.1.4.1146.773 | Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site) |
| 2.16.840.1.113762.1.4.1146.782 | Rubella (Test Panels for rubella virus IgM IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.785 | Opioid Overdose and Poisoning (Tests for Opioids [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.797 | Influenza (Tests for influenza A or B virus by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.798 | Influenza (Tests for influenza A virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.799 | Influenza (Tests for influenza A virus Antigen) |
| 2.16.840.1.113762.1.4.1146.802 | Influenza (Tests for Novel influenza A virus Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.803 | Tests by Microscopic Observation in Tissue by H&E or PAS Stain |
| 2.16.840.1.113762.1.4.1146.815 | NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative]) |
| 2.16.840.1.113762.1.4.1146.816 | Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum) |
| 2.16.840.1.113762.1.4.1146.818 | Measles (Tests for measles virus IgG Antibody [Ratio] in Serum) |
| 2.16.840.1.113762.1.4.1146.820 | Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum) |
| 2.16.840.1.113762.1.4.1146.824 | Computerized Tomography of Chest (Imaging) |
| 2.16.840.1.113762.1.4.1146.830 | Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen) |
| 2.16.840.1.113762.1.4.1146.841 | Tuberculosis (Interferon Gamma Release Assays) |
| 2.16.840.1.113762.1.4.1146.842 | Tests by Microscopic Observation in Tissue |
| 2.16.840.1.113762.1.4.1146.846 | SARS (Tests for SARS_CoV by Culture and Identification Method) |
| 2.16.840.1.113762.1.4.1146.847 | SARS (Tests for SARS_CoV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.878 | MERS (Tests for MERS_CoV Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.884 | Tests by Microscopic Observation in Blood |
| 2.16.840.1.113762.1.4.1146.889 | Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody) |
| 2.16.840.1.113762.1.4.1146.892 | Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain) |
| 2.16.840.1.113762.1.4.1146.896 | Tests by Microscopic Observation in Blood Smear |
| 2.16.840.1.113762.1.4.1146.897 | Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody) |
| 2.16.840.1.113762.1.4.1146.9 | Xray of Chest (Imaging) |
| 2.16.840.1.113762.1.4.1146.900 | Organisms (Tests by Microscopic Observation) |
| 2.16.840.1.113762.1.4.1146.989 | Tests for Mycobacterium species by Culture and Identification Method |
| 2.16.840.1.113762.1.4.1146.994 | Organisms (Tests for Nucleic Acid) |
| 2.16.840.1.113762.1.4.1146.998 | Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid) |
| 2.16.840.1.113762.1.4.1147.109 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| 2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| 2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast |
| 2.16.840.1.113762.1.4.1147.164 | Ultrasound of Lower Extremities |
| 2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities |
| 2.16.840.1.113762.1.4.1147.183 | Anti Factor Xa Assay |
| 2.16.840.1.113762.1.4.1151.38 | DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care |
| 2.16.840.1.113762.1.4.1160.30 | Prediabetes HbA1c Tests |
| 2.16.840.1.113762.1.4.1160.32 | Prediabetes HbA1c Tests |
| 2.16.840.1.113762.1.4.1160.33 | Prediabetes Oral Glucose Tolerance Tests |
| 2.16.840.1.113762.1.4.1160.35 | Prediabetes Oral Glucose Tolerance Tests |
| 2.16.840.1.113762.1.4.1160.36 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests |
| 2.16.840.1.113762.1.4.1160.38 | Prediabetes Fasting plasma glucose or Plasma Glucose Tests |
| 2.16.840.1.113762.1.4.1160.4 | Glycemic Screening Tests |
| 2.16.840.1.113762.1.4.1160.5 | Glycemic Screening Tests |
| 2.16.840.1.113762.1.4.1160.88 | Direct LDL Cholesterol |
| 2.16.840.1.113762.1.4.1160.89 | Calculated LDL Cholesterol |
| 2.16.840.1.113762.1.4.1164.68 | BMI greater than 40 |
| 2.16.840.1.113762.1.4.1164.69 | Morbid Obesity |
| 2.16.840.1.113762.1.4.1166.10 | Pap Smear Tests |
| 2.16.840.1.113762.1.4.1166.11 | HIV Tests |
| 2.16.840.1.113762.1.4.1166.115 | Self Identified Need for Contraception (SINC) |
| 2.16.840.1.113762.1.4.1166.117 | Syphilis Tests |
| 2.16.840.1.113762.1.4.1166.12 | Human Papilloma Virus Tests |
| 2.16.840.1.113762.1.4.1166.13 | Chlamydia Trachomatis Tests |
| 2.16.840.1.113762.1.4.1166.14 | Neisseria Gonorrhoeae Tests |
| 2.16.840.1.113762.1.4.1166.15 | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests |
| 2.16.840.1.113762.1.4.1166.150 | Contraceptive Patch LOINC |
| 2.16.840.1.113762.1.4.1166.160 | Contraceptive Ring LOINC |
| 2.16.840.1.113762.1.4.1166.167 | Contraceptive Implant LOINC |
| 2.16.840.1.113762.1.4.1166.188 | Injectable Contraceptive LOINC |
| 2.16.840.1.113762.1.4.1166.196 | Oral Contraceptive Pill LOINC |
| 2.16.840.1.113762.1.4.1166.211 | Contraceptive discussion |
| 2.16.840.1.113762.1.4.1166.80 | Intrauterine Devices LOINC |
| 2.16.840.1.113762.1.4.1166.98 | Female Sterilization LOINC |
| 2.16.840.1.113762.1.4.1170.32 | Healthcare Agent and Power of Attorney Documentation |
| 2.16.840.1.113762.1.4.1170.33 | Advance Directive Documentation |
| 2.16.840.1.113762.1.4.1170.36 | Portable Medical Order(s) Documentation |
| 2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation |
| 2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation |
| 2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation |
| 2.16.840.1.113762.1.4.1170.58 | Goals, preferences, and priorities for medical treatment |
| 2.16.840.1.113762.1.4.1178.25 | 2 Hour Blood Glucose Test |
| 2.16.840.1.113762.1.4.1178.26 | NYHA Functional Classification |
| 2.16.840.1.113762.1.4.1178.3 | Cholesterol non HDL Laboratory Test |
| 2.16.840.1.113762.1.4.1178.49 | Minnesota Living with Heart Failure Questionnaire |
| 2.16.840.1.113762.1.4.1178.50 | Kansas City Cardiomyopathy Questionnaire |
| 2.16.840.1.113762.1.4.1178.86 | Serum Creatinine |
| 2.16.840.1.113762.1.4.1178.87 | Urine Creatinine |
| 2.16.840.1.113762.1.4.1178.88 | Urine Albumin |
| 2.16.840.1.113762.1.4.1190.21 | NHSNPopulationSummaryReportTypeCode(LOINC) |
| 2.16.840.1.113762.1.4.1190.38 | Blood Glucose Laboratory and Point of Care Tests |
| 2.16.840.1.113762.1.4.1190.62 | Lab Tests for Clostridioides difficile |
| 2.16.840.1.113762.1.4.1190.63 | Bacterial and Fungal Blood Culture Tests |
| 2.16.840.1.113762.1.4.1196.1344 | Tests for Neisseria gonorrhoeae of unspecified site reported by presence |
| 2.16.840.1.113762.1.4.1196.1352 | Body weight |
| 2.16.840.1.113762.1.4.1196.3483 | Financial Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3484 | Food Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3485 | Health Literacy Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3486 | Homelessness Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3487 | Housing Instability Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3488 | Less Than High School Education Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1196.3519 | Health Insurance Coverage Status Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1196.3520 | Inadequate Housing Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1196.4474 | HIV Laboratory Based Tests |
| 2.16.840.1.113762.1.4.1206.57 | Colorectal Screening |
| 2.16.840.1.113762.1.4.1206.59 | Screening Mammogram (LOINC) |
| 2.16.840.1.113762.1.4.1206.61 | Screening Mammogram (Grouping) |
| 2.16.840.1.113762.1.4.1206.63 | Diagnostic Mammography (LOINC) |
| 2.16.840.1.113762.1.4.1206.65 | Diagnostic Mammography |
| 2.16.840.1.113762.1.4.1219.106 | pH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturation |
| 2.16.840.1.113762.1.4.1219.123 | Apnea Hypopnea Index Rate Measurement |
| 2.16.840.1.113762.1.4.1219.124 | Forced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurement |
| 2.16.840.1.113762.1.4.1219.125 | Maximal Inspiratory Pressure Measurement |
| 2.16.840.1.113762.1.4.1219.126 | Forced Vital Capacity (FVC) Measurement by Spirometry |
| 2.16.840.1.113762.1.4.1219.127 | Oxygen Saturation Measurement At Rest |
| 2.16.840.1.113762.1.4.1219.131 | Forced Vital Capacity (FVC) Measurement Prediction |
| 2.16.840.1.113762.1.4.1219.132 | Oxygen Saturation Laboratory Test and Setting for Breathing Assistance Device Evaluation |
| 2.16.840.1.113762.1.4.1219.133 | Respiratory Disturbance Index |
| 2.16.840.1.113762.1.4.1219.94 | Laboratory Test for Home Glucose Monitor Evaluation |
| 2.16.840.1.113762.1.4.1221.135 | Last Menstrual Period (LMP) |
| 2.16.840.1.113762.1.4.1221.172 | Contraception, Counseling |
| 2.16.840.1.113762.1.4.1221.174 | Contraception, Counseling |
| 2.16.840.1.113762.1.4.1221.204 | Pregnancy Labs, Blood/Serum/Plasma/Urine |
| 2.16.840.1.113762.1.4.1222.1005 | Sexual Satisfaction |
| 2.16.840.1.113762.1.4.1222.1015 | Substance Use |
| 2.16.840.1.113762.1.4.1222.1016 | Tobacco Use |
| 2.16.840.1.113762.1.4.1222.1020 | Screen Time |
| 2.16.840.1.113762.1.4.1222.1022 | Fluid Management |
| 2.16.840.1.113762.1.4.1222.1023 | Fat Intake |
| 2.16.840.1.113762.1.4.1222.1024 | Unsaturated Fat Intake |
| 2.16.840.1.113762.1.4.1222.1025 | Saturated Fat Intake |
| 2.16.840.1.113762.1.4.1222.1026 | Carbohydrate Intake |
| 2.16.840.1.113762.1.4.1222.1027 | Salt Intake |
| 2.16.840.1.113762.1.4.1222.1028 | Vegetable Intake |
| 2.16.840.1.113762.1.4.1222.1029 | Fruit Intake |
| 2.16.840.1.113762.1.4.1222.1030 | English Proficiency |
| 2.16.840.1.113762.1.4.1222.1042 | Neglect |
| 2.16.840.1.113762.1.4.1222.1048 | Current or Former Occupation |
| 2.16.840.1.113762.1.4.1222.1050 | Work Productivity |
| 2.16.840.1.113762.1.4.1222.1053 | Income Level |
| 2.16.840.1.113762.1.4.1222.1057 | Caregiver Characteristics |
| 2.16.840.1.113762.1.4.1222.1058 | Caregiver Availability |
| 2.16.840.1.113762.1.4.1222.1060 | Living Situation |
| 2.16.840.1.113762.1.4.1222.1064 | Marital or Spousal Status |
| 2.16.840.1.113762.1.4.1222.1065 | Dependents in Home |
| 2.16.840.1.113762.1.4.1222.1068 | Physical Activity Level |
| 2.16.840.1.113762.1.4.1222.1069 | Leisure Activity Engagement |
| 2.16.840.1.113762.1.4.1222.1075 | Exposure to Environmental Hazards |
| 2.16.840.1.113762.1.4.1222.1076 | Neighborhood Safety |
| 2.16.840.1.113762.1.4.1222.1080 | Experiences of Discrimination |
| 2.16.840.1.113762.1.4.1222.1082 | Criminal Justice Involvement or Incarceration |
| 2.16.840.1.113762.1.4.1222.1083 | Immigration Status |
| 2.16.840.1.113762.1.4.1222.111 | Creatinine in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.113 | Blood Urea Nitrogen |
| 2.16.840.1.113762.1.4.1222.114 | Hemoglobin |
| 2.16.840.1.113762.1.4.1222.118 | Iron Saturation (Transferrin Saturation/TSAT) |
| 2.16.840.1.113762.1.4.1222.119 | Hemoglobin A1C |
| 2.16.840.1.113762.1.4.1222.1197 | Sleep Behavior |
| 2.16.840.1.113762.1.4.1222.120 | Potassium in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.122 | Corrected Calcium |
| 2.16.840.1.113762.1.4.1222.123 | Phosphorus in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.126 | Vitamin D Levels |
| 2.16.840.1.113762.1.4.1222.128 | KT/V Hemodialysis Ratio |
| 2.16.840.1.113762.1.4.1222.129 | Intact Parathyroid Hormone |
| 2.16.840.1.113762.1.4.1222.130 | Bicarbonate in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.131 | Sodium in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.132 | Chloride in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.135 | High Density Lipoprotein |
| 2.16.840.1.113762.1.4.1222.137 | Triglyceride in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.138 | Cystatin C |
| 2.16.840.1.113762.1.4.1222.139 | Total Cholesterol |
| 2.16.840.1.113762.1.4.1222.140 | Ferritin |
| 2.16.840.1.113762.1.4.1222.141 | Red Blood Cell Count (Erythrocytes) |
| 2.16.840.1.113762.1.4.1222.142 | White Blood Cell (Leukocytes) Count |
| 2.16.840.1.113762.1.4.1222.143 | Hematocrit |
| 2.16.840.1.113762.1.4.1222.144 | Mean Corpuscular Volume |
| 2.16.840.1.113762.1.4.1222.145 | Mean Corpuscular Hemoglobin Concentration |
| 2.16.840.1.113762.1.4.1222.146 | Platelet Count |
| 2.16.840.1.113762.1.4.1222.147 | Erythrocyte Distribution Width |
| 2.16.840.1.113762.1.4.1222.148 | Platelet Distribution Width |
| 2.16.840.1.113762.1.4.1222.149 | Platelet Mean Volume |
| 2.16.840.1.113762.1.4.1222.150 | Estimated Average Glucose |
| 2.16.840.1.113762.1.4.1222.151 | Albumin in Blood, Plasma, or Serum |
| 2.16.840.1.113762.1.4.1222.153 | Anion Gap |
| 2.16.840.1.113762.1.4.1222.154 | Urine Urea Nitrogen |
| 2.16.840.1.113762.1.4.1222.155 | Bone Density |
| 2.16.840.1.113762.1.4.1222.156 | Bone Survey X Rays |
| 2.16.840.1.113762.1.4.1222.1568 | Low Density Lipoprotein |
| 2.16.840.1.113762.1.4.1222.1569 | Physical findings of the abdomen |
| 2.16.840.1.113762.1.4.1222.1571 | Chest US |
| 2.16.840.1.113762.1.4.1222.1572 | Sleep Disorder Assessment |
| 2.16.840.1.113762.1.4.1222.1573 | Cerebral Spinal Fluid (CSF) Analysis |
| 2.16.840.1.113762.1.4.1222.1574 | Comprehensive Metabolic Panel (CMP) |
| 2.16.840.1.113762.1.4.1222.1575 | Arterial Blood Gas (ABG) |
| 2.16.840.1.113762.1.4.1222.1576 | Coagulation Assay (PT, aPTT, Fibrinogen) |
| 2.16.840.1.113762.1.4.1222.1577 | D Dimer Test |
| 2.16.840.1.113762.1.4.1222.1578 | Procalcitonin in Blood, Serum, or Plasma |
| 2.16.840.1.113762.1.4.1222.1579 | Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma |
| 2.16.840.1.113762.1.4.1222.1580 | COVID 19 (SARS CoV 2), SARS CoV, Influenza virus A and B Tests |
| 2.16.840.1.113762.1.4.1222.1581 | Microorganisms Detection by Blood Culture |
| 2.16.840.1.113762.1.4.1222.1582 | Microorganisms Detection by Sputum Culture |
| 2.16.840.1.113762.1.4.1222.1583 | Cystography |
| 2.16.840.1.113762.1.4.1222.1584 | Cognitive Health Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1585 | Alcohol Use Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1586 | Functional Status Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1587 | Kidney Disease Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1588 | Long Covid Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1589 | Nutrition Status Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1590 | Pain Perception Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1591 | Patient Goal Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1592 | Social Determinant of Health Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1593 | Covid 19 Related Health Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1594 | Caregiver Considerations Related Questionnaire Panel Codes |
| 2.16.840.1.113762.1.4.1222.1597 | Drugs of Abuse Screen |
| 2.16.840.1.113762.1.4.1222.1598 | Criminal Justice Involvement or Incarceration History |
| 2.16.840.1.113762.1.4.1222.1607 | Alanine Aminotransferase (ALT) in Blood, Plasma, or Serum |
| 2.16.840.1.113762.1.4.1222.1608 | Aspartate Aminotransferase (AST) in Blood, Plasma, or Serum |
| 2.16.840.1.113762.1.4.1222.1609 | Erythrocyte Sedimentation Rate (ESR) in Blood |
| 2.16.840.1.113762.1.4.1222.1610 | Oxygen Saturation in Blood |
| 2.16.840.1.113762.1.4.1222.176 | Urine Sediment |
| 2.16.840.1.113762.1.4.1222.179 | Estimated Glomerular Filtration Rate (eGFR) |
| 2.16.840.1.113762.1.4.1222.450 | CKD Progression Risk |
| 2.16.840.1.113762.1.4.1222.582 | Framingham Risk Assessments |
| 2.16.840.1.113762.1.4.1222.583 | American College of Cardiology or American Heart Association Ascvd Risk Score (acc/aha Ascvd Risk) |
| 2.16.840.1.113762.1.4.1222.591 | Cannabis Use |
| 2.16.840.1.113762.1.4.1222.702 | Binge Drinking |
| 2.16.840.1.113762.1.4.1222.703 | Binge Drinking |
| 2.16.840.1.113762.1.4.1222.706 | Drug Misuse |
| 2.16.840.1.113762.1.4.1222.711 | Fall Risk |
| 2.16.840.1.113762.1.4.1222.790 | Urine Protein to Creatinine Ratio (UPCR) |
| 2.16.840.1.113762.1.4.1222.791 | 24 Hour Urine Volume |
| 2.16.840.1.113762.1.4.1222.792 | 24 Hour Urine Protein Excretion |
| 2.16.840.1.113762.1.4.1222.793 | Total Carbon Dioxide or Bicarbonate in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.794 | Calcium (Not Corrected for Serum Albumin) in Blood, Plasms, or Serum |
| 2.16.840.1.113762.1.4.1222.795 | B Type Natriuretic Peptide [Bnp] in Blood, Serum or Plasma |
| 2.16.840.1.113762.1.4.1222.797 | N Terminal Pro_B_Type Natriuretic Peptide [Nt_Probnp] in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.801 | High Sensitivity Troponin |
| 2.16.840.1.113762.1.4.1222.804 | Aspartate Transaminase or Alanine Aminotransferase Ratio |
| 2.16.840.1.113762.1.4.1222.805 | Alkaline Phosphatase (Alp) in Blood, Serum or Plasma |
| 2.16.840.1.113762.1.4.1222.806 | Gamma Glutamyl Transpeptidase (Ggt) in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.807 | Triiodothyronine in serum or plasma |
| 2.16.840.1.113762.1.4.1222.808 | Fasting Blood Glucose |
| 2.16.840.1.113762.1.4.1222.809 | Random Blood Glucose Test |
| 2.16.840.1.113762.1.4.1222.810 | Uric Acid (Urate) in blood, serum or plasma |
| 2.16.840.1.113762.1.4.1222.811 | Aldosterone/Renin Ratio |
| 2.16.840.1.113762.1.4.1222.812 | Serum Rheumatoid Factor |
| 2.16.840.1.113762.1.4.1222.813 | Blood Ethanol Level |
| 2.16.840.1.113762.1.4.1222.814 | Drugs of Abuse Screen in Hair |
| 2.16.840.1.113762.1.4.1222.815 | Drugs of Abuse Screen in Urine |
| 2.16.840.1.113762.1.4.1222.816 | Drugs of Abuse Screen in Blood |
| 2.16.840.1.113762.1.4.1222.817 | Drugs of Abuse Screen in Tissue |
| 2.16.840.1.113762.1.4.1222.818 | Drugs of Abuse Screen in Body Fluid |
| 2.16.840.1.113762.1.4.1222.819 | Urea Reduction Ratio |
| 2.16.840.1.113762.1.4.1222.822 | Bowel Sounds |
| 2.16.840.1.113762.1.4.1222.823 | Uroflowmetry |
| 2.16.840.1.113762.1.4.1222.826 | Gait Quality |
| 2.16.840.1.113762.1.4.1222.828 | Balance Assessments |
| 2.16.840.1.113762.1.4.1222.836 | Sit to Stand Ability |
| 2.16.840.1.113762.1.4.1222.844 | Alcohol Use (Revised 2021) |
| 2.16.840.1.113762.1.4.1222.845 | Alcohol Use |
| 2.16.840.1.113762.1.4.1222.864 | Kidney Biopsy Report |
| 2.16.840.1.113762.1.4.1222.867 | Skin Biopsy Report |
| 2.16.840.1.113762.1.4.1222.868 | Muscle Biopsy Report |
| 2.16.840.1.113762.1.4.1222.869 | Gastric Tissue Biopsy Report |
| 2.16.840.1.113762.1.4.1222.870 | Bone Biopsy Report |
| 2.16.840.1.113762.1.4.1222.873 | Echocardiogram |
| 2.16.840.1.113762.1.4.1222.880 | Spinal or Back CT |
| 2.16.840.1.113762.1.4.1222.881 | Chest CT |
| 2.16.840.1.113762.1.4.1222.882 | Abdominal or Pelvic CT |
| 2.16.840.1.113762.1.4.1222.883 | Limb CT |
| 2.16.840.1.113762.1.4.1222.884 | Heart Calcium Score |
| 2.16.840.1.113762.1.4.1222.885 | Coronary CT Angiogram |
| 2.16.840.1.113762.1.4.1222.886 | Limb CT Angiogram |
| 2.16.840.1.113762.1.4.1222.888 | Chest CT Angiogram |
| 2.16.840.1.113762.1.4.1222.889 | Head and Neck CT Angiogram |
| 2.16.840.1.113762.1.4.1222.891 | Gastrointestinal Tract X Ray |
| 2.16.840.1.113762.1.4.1222.892 | Gallbladder X Ray |
| 2.16.840.1.113762.1.4.1222.893 | Kidney X Ray |
| 2.16.840.1.113762.1.4.1222.894 | Abdomen X Ray |
| 2.16.840.1.113762.1.4.1222.895 | Pelvis X Ray |
| 2.16.840.1.113762.1.4.1222.896 | Hand X Ray |
| 2.16.840.1.113762.1.4.1222.897 | Wrist X Ray |
| 2.16.840.1.113762.1.4.1222.898 | Forearm X Ray |
| 2.16.840.1.113762.1.4.1222.899 | Elbow X Ray |
| 2.16.840.1.113762.1.4.1222.900 | Upper Arm X Ray |
| 2.16.840.1.113762.1.4.1222.901 | Shoulder X Ray |
| 2.16.840.1.113762.1.4.1222.902 | Upper Extremity X Ray |
| 2.16.840.1.113762.1.4.1222.903 | Foot X Ray |
| 2.16.840.1.113762.1.4.1222.904 | Ankle X Ray |
| 2.16.840.1.113762.1.4.1222.905 | Shin X Ray |
| 2.16.840.1.113762.1.4.1222.906 | Knee X Ray |
| 2.16.840.1.113762.1.4.1222.907 | Thigh X Ray |
| 2.16.840.1.113762.1.4.1222.908 | Hip X Ray |
| 2.16.840.1.113762.1.4.1222.909 | Lower Extremity X Ray |
| 2.16.840.1.113762.1.4.1222.910 | Abdominal MRI |
| 2.16.840.1.113762.1.4.1222.911 | Adrenal Gland MRI |
| 2.16.840.1.113762.1.4.1222.912 | Kidney MRI |
| 2.16.840.1.113762.1.4.1222.913 | Pancreas MRI |
| 2.16.840.1.113762.1.4.1222.915 | Kidney MRA |
| 2.16.840.1.113762.1.4.1222.916 | Chest Region MRI |
| 2.16.840.1.113762.1.4.1222.917 | Pulmonary MRI |
| 2.16.840.1.113762.1.4.1222.918 | Cardiac MRI |
| 2.16.840.1.113762.1.4.1222.920 | Spine MRI |
| 2.16.840.1.113762.1.4.1222.921 | Head and Neck MRI |
| 2.16.840.1.113762.1.4.1222.922 | Brain MRI |
| 2.16.840.1.113762.1.4.1222.923 | Pelvic Region MRI |
| 2.16.840.1.113762.1.4.1222.924 | Knee MRI |
| 2.16.840.1.113762.1.4.1222.925 | Foot MRI |
| 2.16.840.1.113762.1.4.1222.927 | Shoulder MRI |
| 2.16.840.1.113762.1.4.1222.928 | Lower Extremity MRA |
| 2.16.840.1.113762.1.4.1222.930 | Spine X Ray |
| 2.16.840.1.113762.1.4.1222.933 | Hip MRI |
| 2.16.840.1.113762.1.4.1222.934 | Thigh or Femur MRI |
| 2.16.840.1.113762.1.4.1222.935 | Ankle MRI |
| 2.16.840.1.113762.1.4.1222.936 | Lower Extremity MRI |
| 2.16.840.1.113762.1.4.1222.937 | Forearm MRI |
| 2.16.840.1.113762.1.4.1222.938 | Elbow MRI |
| 2.16.840.1.113762.1.4.1222.939 | Wrist MRI |
| 2.16.840.1.113762.1.4.1222.940 | Hand MRI |
| 2.16.840.1.113762.1.4.1222.942 | Upper Extremity MRI |
| 2.16.840.1.113762.1.4.1222.943 | Abdominal MRA |
| 2.16.840.1.113762.1.4.1222.944 | Chest MRA |
| 2.16.840.1.113762.1.4.1222.945 | Upper Extremity MRA |
| 2.16.840.1.113762.1.4.1222.947 | Head and Neck MRA |
| 2.16.840.1.113762.1.4.1222.948 | Pelvic Region MRA |
| 2.16.840.1.113762.1.4.1222.949 | Functional MRI |
| 2.16.840.1.113762.1.4.1222.951 | Optical Coherence Tomography |
| 2.16.840.1.113762.1.4.1222.954 | Bathing or grooming/hygiene (ADL/IADL) |
| 2.16.840.1.113762.1.4.1222.955 | Dressing (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.956 | Toileting (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.957 | Transferring (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.958 | Walking or ambulation/locomotion (ADL/IADL) |
| 2.16.840.1.113762.1.4.1222.960 | Domestic Duties or Household Tasks (ADL/IADL) |
| 2.16.840.1.113762.1.4.1222.961 | Telephone Use (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.962 | Bed Mobility (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.963 | Stair Use (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.964 | Medication Management (ADL or IADL) |
| 2.16.840.1.113762.1.4.1222.967 | Electromyography |
| 2.16.840.1.113762.1.4.1222.968 | Electroencephalogram |
| 2.16.840.1.113762.1.4.1222.969 | Exercise Stress Test |
| 2.16.840.1.113762.1.4.1222.976 | Sleep Duration, Device |
| 2.16.840.1.113762.1.4.1222.977 | Steps Per Time, Device |
| 2.16.840.1.113762.1.4.1222.978 | Physical Activity Level, Device |
| 2.16.840.1.113762.1.4.1222.979 | Cognitive Function Clinician Interpretation |
| 2.16.840.1.113762.1.4.1222.987 | Psychosis |
| 2.16.840.1.113762.1.4.1222.991 | Suicidal Ideation and Behaviors |
| 2.16.840.1.113762.1.4.1222.994 | Sleep Duration |
| 2.16.840.1.113762.1.4.1222.996 | Pain Intensity or Severity |
| 2.16.840.1.113762.1.4.1222.997 | Pain Quality |
| 2.16.840.1.113762.1.4.1228.1 | Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography |
| 2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition |
| 2.16.840.1.113762.1.4.1235.12 | Metabolic Syndrome LOINC |
| 2.16.840.1.113762.1.4.1235.15 | MetabolicSyndromeCondition |
| 2.16.840.1.113762.1.4.1235.175 | Systolic Blood Pressure_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD |
| 2.16.840.1.113762.1.4.1235.179 | Diastolic Blood Pressure_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD |
| 2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.196 | Lipid Panel_Event_LOINC |
| 2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping |
| 2.16.840.1.113762.1.4.1235.201 | Unknown Glucose_Event_LOINC |
| 2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.251 | Asthma_LOINC |
| 2.16.840.1.113762.1.4.1235.253 | Asthma_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.262 | Heart Failure (CHF)_LOINC |
| 2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.284 | HDL_LOINC |
| 2.16.840.1.113762.1.4.1235.285 | HDL_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.292 | CT Colonography_LOINC |
| 2.16.840.1.113762.1.4.1235.294 | CT Colonography_Event_Grouping |
| 2.16.840.1.113762.1.4.1235.295 | FIT DNA_LOINC |
| 2.16.840.1.113762.1.4.1235.299 | FIT DNA Test_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.312 | FOBT Lab_LOINC |
| 2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.330 | High Risk HPV Test_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.335 | Cervical Cytology_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.341 | AFib (Atrial Fibrillation)_LOINC |
| 2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.356 | Coronary Artery Disease (CAD)_LOINC |
| 2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.403 | First Trimester_LOINC |
| 2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.427 | Obesity_Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.428 | Vitals Body Height LOINC |
| 2.16.840.1.113762.1.4.1235.430 | Vitals Body Height |
| 2.16.840.1.113762.1.4.1235.431 | bwell_Vital_Blood Glucose_LOINC |
| 2.16.840.1.113762.1.4.1235.435 | Anxiety_Clinical Grouping Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.437 | bwell_Vital_Blood Oxygen_LOINC |
| 2.16.840.1.113762.1.4.1235.438 | bwell_Vital_Systolic Blood Pressure_LOINC |
| 2.16.840.1.113762.1.4.1235.439 | bwell_Vital_Diastolic Blood Pressure_LOINC |
| 2.16.840.1.113762.1.4.1235.440 | bwell_Vital_Heart Rate_LOINC |
| 2.16.840.1.113762.1.4.1235.441 | bwell_Vital_BMI_LOINC |
| 2.16.840.1.113762.1.4.1235.442 | bwell_Vital_Body Fat_LOINC |
| 2.16.840.1.113762.1.4.1235.443 | bwell_Vital_Body Temperature_LOINC |
| 2.16.840.1.113762.1.4.1235.444 | bwell_Vital_Body Height_LOINC |
| 2.16.840.1.113762.1.4.1235.445 | bwell_Vital_Body Weight_LOINC |
| 2.16.840.1.113762.1.4.1235.446 | bwell_Vital_Respiratory Rate_LOINC |
| 2.16.840.1.113762.1.4.1235.447 | bwell_Vital_Waist Circumference_LOINC |
| 2.16.840.1.113762.1.4.1235.448 | bwell_Vital_Blood Glucose_Clinical Grouping Lab |
| 2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.453 | bwell_Vital_BMI_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.454 | bwell_Vital_Body Fat_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.456 | bwell_Vital_Body Height_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.457 | bwell_Vital_Body Weight_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.458 | bwell_Vital_Respiratory Rate_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.459 | bwell_Vital_Waist Circumference_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.460 | Pregnancy_CN_HD_LOINC |
| 2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.469 | Pregnancy Due Date_LOINC |
| 2.16.840.1.113762.1.4.1235.470 | Second Trimester_LOINC |
| 2.16.840.1.113762.1.4.1235.475 | OGTT_LOINC |
| 2.16.840.1.113762.1.4.1235.476 | OGTT_Grouping |
| 2.16.840.1.113762.1.4.1235.494 | PSA Testing _LOINC |
| 2.16.840.1.113762.1.4.1235.495 | PSA Testing_Grouping |
| 2.16.840.1.113762.1.4.1235.498 | Active Pregnancy_LOINC |
| 2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.506 | Third Trimester_LOINC |
| 2.16.840.1.113762.1.4.1235.513 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINC |
| 2.16.840.1.113762.1.4.1235.514 | bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.529 | Postpartum_LOINC |
| 2.16.840.1.113762.1.4.1235.531 | Postpartum_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.532 | bwell_Vital_Head Circumference_LOINC |
| 2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.535 | bwell_Vital_Body Surface Area_LOINC |
| 2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.538 | bwell_Vital_Vital Signs Panel_LOINC |
| 2.16.840.1.113762.1.4.1235.540 | bwell_Vital_Vital Signs Panel_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.541 | bwell_Vital_Blood Pressure Panel_LOINC |
| 2.16.840.1.113762.1.4.1235.542 | bwell_Vital_Blood Pressure Panel_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.547 | Depression_Clinical Grouping Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.592 | Polypharmacy_Clinical_Grouping_Condition_LOINC |
| 2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant |
| 2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant |
| 2.16.840.1.113762.1.4.1235.609 | bwell Systolic Blood Pressure Vitals_UI_LOINC |
| 2.16.840.1.113762.1.4.1235.611 | bwell Diastolic Blood Pressure Vitals_UI_LOINC |
| 2.16.840.1.113762.1.4.1235.613 | bwell Combo Blood Pressure Vitals_UI_LOINC |
| 2.16.840.1.113762.1.4.1235.615 | bwell Systolic Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.616 | bwell Diastolic Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.617 | bwell Combo Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC |
| 2.16.840.1.113762.1.4.1235.637 | LP(a) Test |
| 2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition |
| 2.16.840.1.113762.1.4.1235.95 | Cardiomyopathy Dilated LOINC |
| 2.16.840.1.113762.1.4.1235.99 | Cardiomyopathy Hypertrophic LOINC |
| 2.16.840.1.113762.1.4.1247.126 | Social Determinants of Health Screening Assessments |
| 2.16.840.1.113762.1.4.1247.127 | Food Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.128 | Transportation Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.129 | Homelessness Screening Assessments |
| 2.16.840.1.113762.1.4.1247.130 | Housing Instability Screening Assessments |
| 2.16.840.1.113762.1.4.1247.131 | Inadequate Housing Screening Assessments |
| 2.16.840.1.113762.1.4.1247.132 | Less Than High School Education Screening Assessments |
| 2.16.840.1.113762.1.4.1247.133 | Unemployment Screening Assessments |
| 2.16.840.1.113762.1.4.1247.134 | Veteran Status Screening Assessments |
| 2.16.840.1.113762.1.4.1247.135 | Social Connection Screening Assessments |
| 2.16.840.1.113762.1.4.1247.136 | Stress Screening Assessments |
| 2.16.840.1.113762.1.4.1247.138 | Financial Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.139 | Material Hardship Screening Assessments |
| 2.16.840.1.113762.1.4.1247.140 | Intimate Partner Violence Screening Assessments |
| 2.16.840.1.113762.1.4.1247.141 | Health Literacy Screening Assessments |
| 2.16.840.1.113762.1.4.1247.142 | Medical Cost Burden Screening Assessments |
| 2.16.840.1.113762.1.4.1247.143 | Health Insurance Coverage Status Screening Assessments |
| 2.16.840.1.113762.1.4.1247.144 | Elder Abuse Screening Assessments |
| 2.16.840.1.113762.1.4.1247.167 | Inadequate Housing Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.168 | Material Hardship Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.169 | Stress Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.170 | Transportation Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.171 | Unemployment Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.172 | Veteran Status Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.173 | Financial Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.174 | Food Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.175 | Health Literacy Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.176 | Homelessness Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.177 | Housing Instability Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.178 | Inadequate Housing Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.179 | Less Than High School Education Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.180 | Material Hardship Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.181 | Stress Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.182 | Transportation Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.183 | Unemployment Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.184 | Veteran Status Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.185 | Health Insurance Coverage Status Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.186 | Health Insurance Coverage Status Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.187 | Medical Cost Burden Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.188 | Medical Cost Burden Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.189 | Elder Abuse Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.190 | Elder Abuse Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.191 | Elder Abuse Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.192 | Veteran Status Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.193 | Financial Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.194 | Food Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.195 | Health Literacy Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.196 | Homelessness Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.197 | Housing Instability Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.198 | Intimate Partner Violence Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.199 | Less Than High School Education Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.200 | Material Hardship Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.201 | Medical Cost Burden Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.202 | Social Connection Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.203 | Stress Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.204 | Transportation Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.205 | Unemployment Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.206 | Social Determinants of Health Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.207 | Social Determinants of Health Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.208 | Social Determinants of Health Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.209 | Intimate Partner Violence Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.210 | Social Connection Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.211 | Intimate Partner Violence Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.212 | Social Connection Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.237 | Digital Access Screening Assessments |
| 2.16.840.1.113762.1.4.1247.238 | Digital Access Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.239 | Digital Access Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.240 | Digital Access Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.248 | Utility Insecurity Screening Assessments |
| 2.16.840.1.113762.1.4.1247.249 | Utility Insecurity Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.250 | Utility Insecurity Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.251 | Utility Insecurity Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1247.270 | Language Access Screening Assessments |
| 2.16.840.1.113762.1.4.1247.271 | Language Access Screening Assessments Answers |
| 2.16.840.1.113762.1.4.1247.272 | Language Access Screening Assessments Questions |
| 2.16.840.1.113762.1.4.1247.273 | Language Access Screening Assessments And Questions |
| 2.16.840.1.113762.1.4.1248.109 | aPTT Tests |
| 2.16.840.1.113762.1.4.1248.21 | Creatinine Mass Per Volume |
| 2.16.840.1.113762.1.4.1248.218 | Blood urea nitrogen lab test |
| 2.16.840.1.113762.1.4.1248.219 | Hemoglobin lab test |
| 2.16.840.1.113762.1.4.1248.221 | Albumin lab test |
| 2.16.840.1.113762.1.4.1248.222 | Leukocyte count lab test |
| 2.16.840.1.113762.1.4.1248.223 | Bilirubin lab test |
| 2.16.840.1.113762.1.4.1248.224 | Aspartate transaminase lab test |
| 2.16.840.1.113762.1.4.1248.301 | LDL Cholesterol |
| 2.16.840.1.113762.1.4.1248.34 | Glucose Lab Test Mass Per Volume |
| 2.16.840.1.113762.1.4.1248.359 | DEXA Bone Density for Urology Care |
| 2.16.840.1.113762.1.4.1248.376 | HIV Viral Load Tests |
| 2.16.840.1.113762.1.4.1248.377 | HIV Viral Load Tests |
| 2.16.840.1.113762.1.4.1248.389 | Syphilis Tests |
| 2.16.840.1.113762.1.4.1248.94 | Oxygen Partial Pressure in Arterial Blood |
| 2.16.840.1.113762.1.4.1248.95 | Carbon Dioxide Partial Pressure in Arterial Blood |
| 2.16.840.1.113762.1.4.1248.96 | Arterial Blood pH |
| 2.16.840.1.113762.1.4.1258.1 | Gonorrhea Screening |
| 2.16.840.1.113762.1.4.1259.4 | eGFR Using 2021 Race Free Formulas |
| 2.16.840.1.113762.1.4.1259.5 | Fructosamine in Serum or Plasma |
| 2.16.840.1.113762.1.4.1259.6 | Glucose tests in venous blood, capillary blood, serum/plasma for Diabetes |
| 2.16.840.1.113762.1.4.1259.7 | Creatinine in serum/plasma |
| 2.16.840.1.113762.1.4.1260.10 | Estrogen Receptor Testing for Orserdu |
| 2.16.840.1.113762.1.4.1260.100 | MMR Proficient |
| 2.16.840.1.113762.1.4.1260.11 | Estrogen Receptor Test for Orserdu |
| 2.16.840.1.113762.1.4.1260.12 | Negative |
| 2.16.840.1.113762.1.4.1260.13 | HER2 Negative |
| 2.16.840.1.113762.1.4.1260.130 | FGFR3 Gene Interpretation Positive LOINC |
| 2.16.840.1.113762.1.4.1260.133 | FGFR3 Gene Interpretation Positive |
| 2.16.840.1.113762.1.4.1260.162 | Adolescent depression screening assessment |
| 2.16.840.1.113762.1.4.1260.163 | Adult depression screening assessment LOINC |
| 2.16.840.1.113762.1.4.1260.200 | EGFR Gene Interpretation Positive LOINC |
| 2.16.840.1.113762.1.4.1260.201 | EGFR Gene Interpretation Positive |
| 2.16.840.1.113762.1.4.1260.202 | EGFR Osimertinib Molecular Variants |
| 2.16.840.1.113762.1.4.1260.205 | EGFR Generic Molecular Variant LOINC |
| 2.16.840.1.113762.1.4.1260.206 | EGFR Molecular Variants Osimertinib PM |
| 2.16.840.1.113762.1.4.1260.217 | MET Gene Test |
| 2.16.840.1.113762.1.4.1260.231 | EGFR Amivantamab Molecular Variants |
| 2.16.840.1.113762.1.4.1260.232 | EGFR Molecular Variants Amivantamab PM |
| 2.16.840.1.113762.1.4.1260.234 | ROS1 Molecular Variants Repotrectinib PM |
| 2.16.840.1.113762.1.4.1260.258 | ALK results (HGNC) |
| 2.16.840.1.113762.1.4.1260.286 | Encorafenib PM Molecular variant |
| 2.16.840.1.113762.1.4.1260.289 | BRAF test (HGNC) |
| 2.16.840.1.113762.1.4.1260.29 | HER2 Positive |
| 2.16.840.1.113762.1.4.1260.304 | HER2 Negative (geneinterpretation/Labtestvalue) LOINC |
| 2.16.840.1.113762.1.4.1260.307 | HER2 Negative (geneinterpretation/Labtestvalue) |
| 2.16.840.1.113762.1.4.1260.318 | Solid Cancer T Stage LOINC |
| 2.16.840.1.113762.1.4.1260.32 | HER2 Positive |
| 2.16.840.1.113762.1.4.1260.320 | Solid Cancer T Stage codes |
| 2.16.840.1.113762.1.4.1260.354 | Progesterone_receptor_labtest |
| 2.16.840.1.113762.1.4.1260.356 | Estrogen_receptor_labtest |
| 2.16.840.1.113762.1.4.1260.360 | HER2_IHC_test_Lab |
| 2.16.840.1.113762.1.4.1260.361 | HER2_Fish_test |
| 2.16.840.1.113762.1.4.1260.371 | HER2 test_Lab |
| 2.16.840.1.113762.1.4.1260.376 | RET mutation_Molecular Variants |
| 2.16.840.1.113762.1.4.1260.387 | RET test_Thyroid_cancer (HGNC) |
| 2.16.840.1.113762.1.4.1260.398 | KRAS_gene |
| 2.16.840.1.113762.1.4.1260.417 | KRAS_G12C_PM |
| 2.16.840.1.113762.1.4.1260.444 | MMR_Gene_Lab_LOINC |
| 2.16.840.1.113762.1.4.1260.447 | MMR_Gene_HGNC |
| 2.16.840.1.113762.1.4.1260.49 | MSI Testing |
| 2.16.840.1.113762.1.4.1260.501 | Test 23 |
| 2.16.840.1.113762.1.4.1260.53 | MMR Gene Testing |
| 2.16.840.1.113762.1.4.1260.54 | MSI High |
| 2.16.840.1.113762.1.4.1260.55 | MSI High |
| 2.16.840.1.113762.1.4.1260.59 | MMR Deficient |
| 2.16.840.1.113762.1.4.1260.60 | MMR Deficient |
| 2.16.840.1.113762.1.4.1260.7 | Her2 Test For Orserdu |
| 2.16.840.1.113762.1.4.1260.81 | RAS Genes |
| 2.16.840.1.113762.1.4.1260.82 | RAS Gene Interpretation Negative LOINC |
| 2.16.840.1.113762.1.4.1260.85 | RAS Gene Negative |
| 2.16.840.1.113762.1.4.1260.87 | RAS Gene Interpretation Positive LOINC |
| 2.16.840.1.113762.1.4.1260.88 | RAS Gene Positive |
| 2.16.840.1.113762.1.4.1260.89 | Her2 Testing |
| 2.16.840.1.113762.1.4.1260.93 | MSI Low LOINC |
| 2.16.840.1.113762.1.4.1260.95 | MSI Low |
| 2.16.840.1.113762.1.4.1260.98 | MMR Proficient LOINC |
| 2.16.840.1.113762.1.4.1264.27 | Legionella Presence by Urine Antigen or DNA |
| 2.16.840.1.113762.1.4.1267.1 | Problem Type |
| 2.16.840.1.113762.1.4.1267.13 | Screening and Assessment Survey Codes |
| 2.16.840.1.113762.1.4.1267.17 | Common LOINC Lab Codes |
| 2.16.840.1.113762.1.4.1267.18 | Radiology Procedures (LOINC) |
| 2.16.840.1.113762.1.4.1267.19 | Clinical Tests |
| 2.16.840.1.113762.1.4.1267.21 | Universal Common LOINC Lab Orders |
| 2.16.840.1.113762.1.4.1267.27 | Social History Type (LOINC) |
| 2.16.840.1.113762.1.4.1267.28 | Social History Type |
| 2.16.840.1.113762.1.4.1267.4 | Smoking Status Type LOINC |
| 2.16.840.1.113762.1.4.1267.6 | Smoking Status Type |
| 2.16.840.1.113762.1.4.1290.4 | Sequential Organ Failure Assessment SOFA |
| 2.16.840.1.113883.1.11.20.2.3 | ReferralDocumentType |
| 2.16.840.1.113883.1.11.20.2.4 | TransferDocumentType |
| 2.16.840.1.113883.1.11.20.2.5 | Wound Measurements |
| 2.16.840.1.113883.1.11.20.22 | HPDocumentType |
| 2.16.840.1.113883.10.20.22.5.305 | Microbiology and Antimicrobial Susceptibility Tests |
| 2.16.840.1.113883.10.20.5.9.10 | Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Data |
| 2.16.840.1.113883.10.20.5.9.4 | NHSNDrugSusceptibilityTestMethod |
| 2.16.840.1.113883.11.20.1.1 | SurgicalOperationNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.4.1 | DischargeSummaryDocumentTypeCode |
| 2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes |
| 2.16.840.1.113883.11.20.8.1 | ProgressNoteDocumentTypeCode |
| 2.16.840.1.113883.11.20.9.31 | ConsultDocumentType |
| 2.16.840.1.113883.11.20.9.32 | DIRDocumentTypeCodes |
| 2.16.840.1.113883.11.20.9.47 | ADL Result Type |
| 2.16.840.1.113883.11.20.9.59 | DIRSectionTypeCodes |
| 2.16.840.1.113883.11.20.9.65 | Physical Exam Type |
| 2.16.840.1.113883.11.20.9.68 | Note Types |
| 2.16.840.1.113883.11.20.9.69.4 | Advance Healthcare Directive Categories LOINC |
| 2.16.840.1.113883.11.20.9.69.5 | Advance Directives Content Types |
| 2.16.840.1.113883.11.20.9.81 | Estimated Date of Delivery Including Method |
| 2.16.840.1.113883.11.20.9.82 | Estimated Gestational Age Code Including Method |
| 2.16.840.1.113883.11.20.9.84 | Other Pregnancy Outcome |
| 2.16.840.1.113883.13.15 | NHSNDrugSusceptibilityTestsCode |
| 2.16.840.1.113883.3.117.1.7.1.213 | INR |
| 2.16.840.1.113883.3.117.1.7.1.215 | LDLc |
| 2.16.840.1.113883.3.1444.3.103 | HER2 Presence in Tissue |
| 2.16.840.1.113883.3.1444.3.104 | Depression Screening for Adult |
| 2.16.840.1.113883.3.1444.3.107 | Standardized Assessment Tools for Dyspnea |
| 2.16.840.1.113883.3.1444.3.108 | Nausea or Vomiting Assessment |
| 2.16.840.1.113883.3.1444.3.114 | Karnofsky Performance Status |
| 2.16.840.1.113883.3.1444.3.203 | BRCA1 |
| 2.16.840.1.113883.3.1444.3.204 | BRCA2 |
| 2.16.840.1.113883.3.1444.3.211 | BRCA1 and BRCA2 |
| 2.16.840.1.113883.3.1444.3.213 | BRAF V600 |
| 2.16.840.1.113883.3.1444.3.216 | BRAF V600 Mutation Status |
| 2.16.840.1.113883.3.1444.5.207 | HER2 Presence in Tissue |
| 2.16.840.1.113883.3.1444.5.209 | Depression Screening for Adult |
| 2.16.840.1.113883.3.1444.5.218 | Dyspnea Assessment |
| 2.16.840.1.113883.3.1444.5.219 | Nausea or Vomiting Assessment |
| 2.16.840.1.113883.3.1444.5.220 | Karnofsky Performance Status |
| 2.16.840.1.113883.3.464.1003.108.11.1044 | Pap Test |
| 2.16.840.1.113883.3.464.1003.108.11.1047 | Mammography |
| 2.16.840.1.113883.3.464.1003.108.11.1145 | sDNA FIT Test |
| 2.16.840.1.113883.3.464.1003.108.12.1017 | Pap Test |
| 2.16.840.1.113883.3.464.1003.108.12.1018 | Mammography |
| 2.16.840.1.113883.3.464.1003.108.12.1038 | CT Colonography |
| 2.16.840.1.113883.3.464.1003.108.12.1039 | sDNA FIT Test |
| 2.16.840.1.113883.3.464.1003.110.11.1128 | Lab Tests for Sexually Transmitted Infections |
| 2.16.840.1.113883.3.464.1003.110.11.1129 | Chlamydia Screening |
| 2.16.840.1.113883.3.464.1003.110.11.1135 | HPV Test |
| 2.16.840.1.113883.3.464.1003.110.12.1051 | Lab Tests for Sexually Transmitted Infections |
| 2.16.840.1.113883.3.464.1003.110.12.1052 | Chlamydia Screening |
| 2.16.840.1.113883.3.464.1003.110.12.1059 | HPV Test |
| 2.16.840.1.113883.3.464.1003.111.11.1012 | Lab Tests During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.11.1013 | Diagnostic Studies During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.11.1019 | Pregnancy Test |
| 2.16.840.1.113883.3.464.1003.111.12.1007 | Lab Tests During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.12.1008 | Diagnostic Studies During Pregnancy |
| 2.16.840.1.113883.3.464.1003.111.12.1011 | Pregnancy Test |
| 2.16.840.1.113883.3.464.1003.113.11.1083 | Central DXA of Hip or Spine |
| 2.16.840.1.113883.3.464.1003.113.11.1202 | DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine |
| 2.16.840.1.113883.3.464.1003.113.12.1051 | DXA (Dual energy Xray Absorptiometry) Scan |
| 2.16.840.1.113883.3.464.1003.118.11.1077 | Falls Screening |
| 2.16.840.1.113883.3.464.1003.118.11.1097 | CT Colonography |
| 2.16.840.1.113883.3.464.1003.118.12.1028 | Falls Screening |
| 2.16.840.1.113883.3.464.1003.120.11.1004 | HIV Viral Load |
| 2.16.840.1.113883.3.464.1003.120.12.1002 | HIV Viral Load |
| 2.16.840.1.113883.3.464.1003.121.11.1028 | BMI percentile |
| 2.16.840.1.113883.3.464.1003.121.11.1030 | Height |
| 2.16.840.1.113883.3.464.1003.121.11.1031 | Weight |
| 2.16.840.1.113883.3.464.1003.121.12.1006 | Consultant Report |
| 2.16.840.1.113883.3.464.1003.121.12.1012 | BMI percentile |
| 2.16.840.1.113883.3.464.1003.121.12.1014 | Height |
| 2.16.840.1.113883.3.464.1003.121.12.1015 | Weight |
| 2.16.840.1.113883.3.464.1003.1266 | Diabetic Retinopathy Severity Level |
| 2.16.840.1.113883.3.464.1003.198.11.1020 | Fecal Occult Blood Test (FOBT) |
| 2.16.840.1.113883.3.464.1003.198.11.1023 | Group A Streptococcus Test |
| 2.16.840.1.113883.3.464.1003.198.11.1024 | HbA1c Laboratory Test |
| 2.16.840.1.113883.3.464.1003.198.11.1055 | XRay Study |
| 2.16.840.1.113883.3.464.1003.198.12.1011 | Fecal Occult Blood Test (FOBT) |
| 2.16.840.1.113883.3.464.1003.198.12.1012 | Group A Streptococcus Test |
| 2.16.840.1.113883.3.464.1003.198.12.1013 | HbA1c Laboratory Test |
| 2.16.840.1.113883.3.464.1003.198.12.1034 | XRay Study |
| 2.16.840.1.113883.3.464.1004.2616 | Autonomous Eye Exam Result or Finding |
| 2.16.840.1.113883.3.526.2.1069 | Standardized Tools for Assessment of Cognition |
| 2.16.840.1.113883.3.526.2.1073 | Standardized Pain Assessment Tool |
| 2.16.840.1.113883.3.526.2.1238 | Ejection Fraction |
| 2.16.840.1.113883.3.526.2.1341 | Heart Rate |
| 2.16.840.1.113883.3.526.2.1364 | Macular Exam |
| 2.16.840.1.113883.3.526.2.1372 | Tobacco Use Screening |
| 2.16.840.1.113883.3.526.2.1374 | Bone Scan |
| 2.16.840.1.113883.3.526.2.1402 | Cup to Disc Ratio |
| 2.16.840.1.113883.3.526.2.1403 | Optic Disc Exam for Structural Abnormalities |
| 2.16.840.1.113883.3.526.2.1781 | Best Corrected Visual Acuity Exam Using Snellen Chart |
| 2.16.840.1.113883.3.526.3.1006 | Standardized Tools Score for Assessment of Cognition |
| 2.16.840.1.113883.3.526.3.1028 | Standardized Pain Assessment Tool |
| 2.16.840.1.113883.3.526.3.1134 | Ejection Fraction |
| 2.16.840.1.113883.3.526.3.1176 | Heart Rate |
| 2.16.840.1.113883.3.526.3.1251 | Macular Exam |
| 2.16.840.1.113883.3.526.3.1278 | Tobacco Use Screening |
| 2.16.840.1.113883.3.526.3.1333 | Cup to Disc Ratio |
| 2.16.840.1.113883.3.526.3.1334 | Optic Disc Exam for Structural Abnormalities |
| 2.16.840.1.113883.3.526.3.1560 | Best Corrected Visual Acuity Exam Using Snellen Chart |
| 2.16.840.1.113883.3.526.3.1573 | LDL Cholesterol |
| 2.16.840.1.113883.3.526.3.320 | Bone Scan |
| 2.16.840.1.113883.3.526.3.401 | Prostate Specific Antigen Test |
| 2.16.840.1.113883.3.600.1482 | Laboratory Tests for Hypertension |
| 2.16.840.1.113883.3.600.2462 | Laboratory Tests for Hypertension |
| 2.16.840.1.113883.3.666.5.2363 | Creatinine Lab Test |
| 2.16.840.1.113883.3.67.1.101.1.263 | PHQ 9 and PHQ 9M Tools |
| 2.16.840.1.113883.3.67.1.101.1.279 | HBsAg |
| 2.16.840.1.113883.3.67.1.101.1.281 | HBsAg |
| 2.16.840.1.113883.3.67.1.101.11.723 | PHQ-9 Tool |
| 2.16.840.1.113883.3.6929.2.1000 | Estimated Glomerular Filtration Rate |
| 2.16.840.1.113883.3.6929.2.1002 | Urine Albumin Creatinine Ratio |
| 2.16.840.1.113883.3.6929.3.1000 | Estimated Glomerular Filtration Rate |
| 2.16.840.1.113883.3.6929.3.1007 | Urine Albumin Creatinine Ratio |
| 2.16.840.1.113883.3.8420.2.1005 | Pediatric Best Corrected Visual Acuity Exam |
| 2.16.840.1.113883.3.8420.2.1006 | LogMAR Visual Acuity Exam |
| 2.16.840.1.113883.3.8420.3.1003 | Pediatric Best Corrected Visual Acuity Exam |
| 2.16.840.1.113883.3.8420.3.1004 | LogMAR Visual Acuity Exam |
| 2.16.840.1.113883.3.88.12.80.62 | Vital Sign Result Type |
| 2.16.840.1.113883.4.642.3.155 | Care Team Category |
| 2.16.840.1.114222.24.7.280 | NHSNGenotypicTests |
| 2.16.840.1.114222.4.11.3595 | NHSNPopulationSummaryReportTypeCode |
| 2.16.840.1.114222.4.11.7160 | NHSNStaphAureusSpecificTest |
| ImageCategory | ImagingStudy Category Type |
| jdv-acte-obp-cisis | JDV Acte Obp CISIS |
| jdv-addiction-cisis | JDV Addiction CISIS |
| jdv-antecedent-obstetrical-cisis | JDV Antecedent Obstetrical CISIS |
| jdv-antecedent-obstetrical-obp-cisis | JDV Antecedent Obstetrical Obp CISIS |
| jdv-batterie-examen-cisis | JDV Batterie Examen CISIS |
| jdv-bilan-technique-cisis | JDV Bilan Technique CISIS |
| jdv-code-document-imagerie-cisis | JDV Code Document Imagerie CISIS |
| jdv-delimitation-activite-cisis | JDV Delimitation Activite CISIS |
| jdv-disposition-pretherapeutique-cisis | JDV Disposition Pretherapeutique CISIS |
| jdv-evaluation-depression-geriatrique30-cisis | JDV Evaluation Depression Geriatrique 30 CISIS |
| jdv-evenement-accouchement-cisis | JDV Evenement Accouchement CISIS |
| jdv-examen-biochimie-aunv-cisis | JDV Examen Biochimie Aunv CISIS |
| jdv-examen-biochimie-eunv-cisis | JDV Examen Biochimie Eunv CISIS |
| jdv-examen-hematologie-aunv-cisis | JDV Examen Hematologie Aunv CISIS |
| jdv-examen-hematologie-eunv-cisis | JDV Examen Hematologie Eunv CISIS |
| jdv-examen-hemostase-aunv-cisis | JDV Examen Hemostase Aunv CISIS |
| jdv-examen-hemostase-eunv-cisis | JDV Examen Hemostase Eunv CISIS |
| jdv-info-deces-cs8-cisis | JDV Info Deces Cs8 CISIS |
| jdv-investigation-realisee-sunv-cisis | JDV Investigation Realisee Sunv CISIS |
| jdv-mesure-lentille-delivree-cisis | JDV Mesure Lentille Delivree CISIS |
| jdv-mesure-lentille-prescrite-cisis | JDV Mesure Lentille Prescrite CISIS |
| jdv-mesure-type-verre-delivre-cisis | JDV Mesure Type Verre Delivre CISIS |
| jdv-mesure-type-verre-prescrit-cisis | JDV Mesure Type Verre Prescrit CISIS |
| jdv-mesure-verre-delivre-cisis | JDV Mesure Verre Delivre CISIS |
| jdv-mesure-verre-prescrit-cisis | JDV Mesure Verre Prescrit CISIS |
| jdv-nihss-ataxie-cisis | JDV Nihss Ataxie CISIS |
| jdv-nihss-champ-visuel-cisis | JDV Nihss Champ Visuel CISIS |
| jdv-nihss-commandes-cisis | JDV Nihss Commandes CISIS |
| jdv-nihss-conscience-cisis | JDV Nihss Conscience CISIS |
| jdv-nihss-dysarthrie-cisis | JDV Nihss Dysarthrie CISIS |
| jdv-nihss-fonction-cisis | JDV Nihss Fonction CISIS |
| jdv-nihss-langage-cisis | JDV Nihss Langage CISIS |
| jdv-nihss-motricite-membre-inferieur-cisis | JDV Nihss Motricite Membre Inferieur CISIS |
| jdv-nihss-motricite-membre-superieur-cisis | JDV Nihss Motricite Membre Superieur CISIS |
| jdv-nihss-negligence-cisis | JDV Nihss Negligence CISIS |
| jdv-nihss-occulomotricite-cisis | JDV Nihss Occulomotricite CISIS |
| jdv-nihss-paralysie-faciale-cisis | JDV Nihss Paralysie Faciale CISIS |
| jdv-nihss-questions-cisis | JDV Nihss Questions CISIS |
| jdv-nihss-sensibilite-cisis | JDV Nihss Sensibilite CISIS |
| jdv-obp-resultat-evenement-cisis | JDV Obp Resultat Evenement CISIS |
| jdv-observation-enfant-cisis | JDV Observation Enfant CISIS |
| jdv-observation-grossesse-cisis | JDV Observation Grossesse CISIS |
| jdv-score-braden-activite-cisis | JDV Score Braden Activite CISIS |
| jdv-score-braden-component-cisis | JDV Score Braden Component CISIS |
| jdv-score-braden-friction-cisaillement-cisis | JDV Score Braden Friction Cisaillement CISIS |
| jdv-score-braden-humidite-cisis | JDV Score Braden Humidite CISIS |
| jdv-score-braden-mobilite-cisis | JDV Score Braden Mobilite CISIS |
| jdv-score-braden-nutrition-cisis | JDV Score Braden Nutrition CISIS |
| jdv-score-braden-perception-sensorielle-cisis | JDV Score Braden Perception Sensorielle CISIS |
| jdv-score-performance-ecog-cisis | JDV Score Performance Ecog CISIS |
| jdv-score-rankin-cisis | JDV Score Rankin CISIS |
| jdv-signe-vital-cisis | JDV Signe Vital CISIS |
| jdv-signe-vital-cs24-cisis | JDV Signe Vital Cs24 CISIS |
| jdv-signe-vital-cs8-cisis | JDV Signe Vital Cs8 CISIS |
| jdv-signe-vital-cs9-cisis | JDV Signe Vital Cs9 CISIS |
| jdv-social-history-code-cisis | JDV Social History Code CISIS |
| jdv-type-de-mesure-acuite-visuelle-cisis | JDV Type De Mesure Acuite Visuelle CISIS |
| jdv-type-de-mesure-de-refraction-cisis | JDV Type De Mesure De Refraction CISIS |
| jdv-type-de-mesure-dispositif-oculaire-cisis | JDV Type De Mesure Dispositif Oculaire CISIS |
| jdv-type-de-test-realise-ccu-cisis | JDV Type De Test Realise Ccu CISIS |
| jdv-type-directive-anticipee-cisis | JDV Type Directive Anticipee CISIS |
| jdv-ufcv-code-entree-cisis | JDV UFCV Code Entree CISIS |
| myhealthway-doc-type-codes | MyHealthWay Document Type Codes |
| myhealthway-loinc-codes | MyHealthWay LOINC Codes |
| anforderung-histologischeAbklaerung | ValueSet - nNGM - Anforderung Histologische Abklärung |
| ecog | nNGM: ValueSet ECOG |
| raucherstatus | ValueSet - nNGM - Raucherstatus |
| tnm-art | ValueSet - nNGM - TNM-Art |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem loinc-fragment-livd
Properties
This code system defines the following properties for its concepts
| Name | Code | URI | Type | Description |
| COMPONENT | COMPONENT | http://loinc.org/property/COMPONENT | Coding | First major axis-component or analyte: Analyte Name, Analyte sub-class, Challenge |
| PROPERTY | PROPERTY | http://loinc.org/property/PROPERTY | Coding | Second major axis-property observed: Kind of Property (also called kind of quantity) |
| TIME_ASPCT | TIME_ASPCT | http://loinc.org/property/TIME_ASPCT | Coding | Third major axis-timing of the measurement: Time Aspect (Point or moment in time vs. time interval) |
| SYSTEM | SYSTEM | http://loinc.org/property/SYSTEM | Coding | Fourth major axis-type of specimen or system: System (Sample) Type |
| SCALE_TYP | SCALE_TYP | http://loinc.org/property/SCALE_TYP | Coding | Fifth major axis-scale of measurement: Type of Scale |
| METHOD_TYP | METHOD_TYP | http://loinc.org/property/METHOD_TYP | Coding | Sixth major axis-method of measurement: Type of Method |
Concepts
This case-insensitive code system http://loinc.org provides a fragment that includes following codes:
FHIR{
"resourceType": "CodeSystem",
"id": "loinc-fragment-livd",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/livd/StructureDefinition/codesystem-loinc-frag-uv-livd"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "http://loinc.org",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.6.1"
}
],
"version": "2.65",
"name": "LOINC",
"title": "LOINC Code System",
"status": "active",
"date": "2024-12-19T18:01:42+00:00",
"publisher": "Regenstrief Institute, Inc.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001"
}
]
}
],
"copyright": "This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use",
"caseSensitive": false,
"content": "fragment",
"property": [
{
"code": "COMPONENT",
"uri": "http://loinc.org/property/COMPONENT",
"description": "First major axis-component or analyte: Analyte Name, Analyte sub-class, Challenge",
"type": "Coding"
},
{
"code": "PROPERTY",
"uri": "http://loinc.org/property/PROPERTY",
"description": "Second major axis-property observed: Kind of Property (also called kind of quantity)",
"type": "Coding"
},
{
"code": "TIME_ASPCT",
"uri": "http://loinc.org/property/TIME_ASPCT",
"description": "Third major axis-timing of the measurement: Time Aspect (Point or moment in time vs. time interval)",
"type": "Coding"
},
{
"code": "SYSTEM",
"uri": "http://loinc.org/property/SYSTEM",
"description": "Fourth major axis-type of specimen or system: System (Sample) Type",
"type": "Coding"
},
{
"code": "SCALE_TYP",
"uri": "http://loinc.org/property/SCALE_TYP",
"description": "Fifth major axis-scale of measurement: Type of Scale",
"type": "Coding"
},
{
"code": "METHOD_TYP",
"uri": "http://loinc.org/property/METHOD_TYP",
"description": "Sixth major axis-method of measurement: Type of Method",
"type": "Coding"
}
],
"concept": [
{
"code": "90370-8",
"display": "LIVD mapping data set",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP269198-0",
"display": "Vendor test code to LOINC mapping data set"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6813-2",
"display": "Find"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP76022-0",
"display": "{Device}"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP32888-7",
"display": "Doc"
}
}
]
},
{
"code": "14749-6",
"display": "Glucose [Moles/volume] in Serum or Plasma",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6860-3",
"display": "SCnc"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7576-4",
"display": "Ser/Plas"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "2345-7",
"display": "Glucose [Mass/volume] in Serum or Plasma",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6827-2",
"display": "MCnc"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7576-4",
"display": "Ser/Plas"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "14744-7",
"display": "Glucose [Moles/volume] in Cerbral spinal fluid",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6860-3",
"display": "SCnc"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7156-5",
"display": "CSF"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "2342-4",
"display": "Glucose [Mass/volume] in Cerebral spinal fluid",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6827-2",
"display": "MCnc"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7156-5",
"display": "CSF"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "15076-3",
"display": "Glucose [Moles/volume] in Urine",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6860-3",
"display": "SCnc"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7681-2",
"display": "Urine"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "2350-7",
"display": "Glucose [Mass/volume] in Urine",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6827-2",
"display": "MCnc"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7681-2",
"display": "Urine"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "15077-1",
"display": "Glucose [Moles/time] in 24 hour Urine",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6867-8",
"display": "SRat"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6924-7",
"display": "24H"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7681-2",
"display": "Urine"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "2351-5",
"display": "Glucose [Mass/time] in 24 hour Urine",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14635-4",
"display": "Glucose"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6833-0",
"display": "MRat"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6924-7",
"display": "24H"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7681-2",
"display": "Urine"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7753-9",
"display": "Qn"
}
}
]
},
{
"code": "70151-6",
"display": "Opiates [Presence] in Urine by Screen method >300 ng/mL",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14565-3",
"display": "Opiates"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP217195-9",
"display": "PrThr"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7681-2",
"display": "Urine"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7751-3",
"display": "Ord"
}
},
{
"code": "METHOD_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP36647-3",
"display": "Screen>300 ng/mL"
}
}
]
},
{
"code": "21431-2",
"display": "Opiates [Presence] in Urine by Screen method >2000 ng/mL",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP14565-3",
"display": "Opiates"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP217195-9",
"display": "PrThr"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7681-2",
"display": "Urine"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7751-3",
"display": "Ord"
}
},
{
"code": "METHOD_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6504-7",
"display": "Screen>2000 ng/mL"
}
}
]
},
{
"code": "22314-9",
"display": "Hepatitis A virus IgM Ab [Presence] in Serum",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP38318-9",
"display": "Hepatitis A virus Ab.IgM"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP217195-9",
"display": "PrThr"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7567-3",
"display": "Ser"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7751-3",
"display": "Ord"
}
}
]
},
{
"code": "31616-6",
"display": "Rubella virus IgM Ab [Presence] in Serum",
"property": [
{
"code": "COMPONENT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP39632-2",
"display": "Rubella virus Ab.IgM"
}
},
{
"code": "PROPERTY",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP217195-9",
"display": "PrThr"
}
},
{
"code": "TIME_ASPCT",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP6960-1",
"display": "Pt"
}
},
{
"code": "SYSTEM",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7567-3",
"display": "Ser"
}
},
{
"code": "SCALE_TYP",
"valueCoding": {
"system": "http://loinc.org",
"code": "LP7751-3",
"display": "Ord"
}
}
]
},
{
"code": "LP269198-0",
"display": "Vendor test code to LOINC mapping data set"
},
{
"code": "LP6813-2",
"display": "Find"
},
{
"code": "LP6960-1",
"display": "Pt"
},
{
"code": "LP76022-0",
"display": "{Device}"
},
{
"code": "LP32888-7",
"display": "Doc"
},
{
"code": "LP14635-4",
"display": "Glucose"
},
{
"code": "LP6860-3",
"display": "SCnc"
},
{
"code": "LP7576-4",
"display": "Ser/Plas"
},
{
"code": "LP7753-9",
"display": "Qn"
},
{
"code": "LP6827-2",
"display": "MCnc"
},
{
"code": "LP7156-5",
"display": "CSF"
},
{
"code": "LP7681-2",
"display": "Urine"
},
{
"code": "LP6867-8",
"display": "SRat"
},
{
"code": "LP6924-7",
"display": "24H"
},
{
"code": "LP6833-0",
"display": "MRat"
},
{
"code": "LP14565-3",
"display": "Opiates"
},
{
"code": "LP217195-9",
"display": "PrThr"
},
{
"code": "LP7751-3",
"display": "Ord"
},
{
"code": "LP36647-3",
"display": "Screen>300 ng/mL"
},
{
"code": "LP6504-7",
"display": "Screen>2000 ng/mL"
},
{
"code": "LP38318-9",
"display": "Hepatitis A virus Ab.IgM"
},
{
"code": "LP7567-3",
"display": "Ser"
},
{
"code": "LP39632-2",
"display": "Rubella virus Ab.IgM"
},
{
"code": "LP16413-4",
"display": "Hemoglobin A1c"
},
{
"code": "LP6866-0",
"display": "SFr"
},
{
"code": "LP7057-5",
"display": "Bld"
},
{
"code": "LP99992-7",
"display": "IFCC"
},
{
"code": "LP6831-4",
"display": "MFr"
},
{
"code": "LP6165-7",
"display": "Calculated"
}
]
}